Dilated cardiomyopathy

I9_DILATED_CARDIOMYOPATHY

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I42.0 Cause of death: ICD-10 — I42.0 2 out of 7 registries used, show all original rules.	5429
4. Check minimum number of events None	5429
5. Include endpoints None	5429
6. Filter based on genotype QC (FinnGen only)	4871

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF13

NAME	I9_DILATED_CARDIOMYOPATHY
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I420
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I420
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Dilated cardiomyopathy based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4871	1229	3642
Unadjusted period prevalence (%)	1.36	0.44	1.67
Median age at first event (years)	62.52	61.80	62.77

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4988: Matched controls
49880

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Z94.1

ICD-10 Finland

Heart transplant status

75.6

312.8

168

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

4.3

307.7

1064

2970

I50

ICD-10 Finland

Heart failure

8.3

307.7

583

783

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

65.7

307.7

764

137

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

16.8

307.7

436

283

I44.7

ICD-10 Finland

Left bundle-branch block, unspecified

17.4

307.7

543

348

TFP20

NOMESCO Finland

Cardiodefibrillation

4.6

307.7

998

2547

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

108.1

307.7

1335

168

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

7.1

307.7

3168

9849

B01AA03

ATC

warfarin; systemic

5.6

307.7

2537

7751

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

81.9

307.7

315

C01AA05

ATC

digoxin; systemic

8.2

307.7

1484

2440

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

12.3

307.7

1777

2140

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

11.3

307.7

1082

1192

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

25.7

307.7

491

211

I42.2

ICD-10 Finland

Other hypertrophic cardiomyopathy

20.2

307.7

277

145

C03CA01

ATC

furosemide; systemic

10.6

307.7

3892

12488

FPE37

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

94.0

307.7

284

A10BK01

ATC

dapagliflozin; oral

4.7

307.7

1034

2648

1CX08, ,

NOMESCO Finland

38.4

307.7

224

201

Kela drug reimbursment

Chronic cardiac insufficiency

49.6

307.7

2990

1461

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

23.7

307.7

302

135

207

Kela drug reimbursment

Chronic arrhythmias

4.8

307.7

2029

6264

I48

ICD-10 Finland

Atrial fibrillation and flutter

4.5

307.7

2514

9162

250, ,

Kela drug reimbursment

17.7

307.7

753

496

C09DX04

ATC

valsartan and sacubitril; oral

73.9

307.7

849

138

AN1

Coronary angiography

5.4

307.7

1666

4208

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

6.9

307.7

2652

7049

C03DA01

ATC

spironolactone; oral

18.5

307.7

3069

3967

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

35.1

307.7

316

C07AB07

ATC

bisoprolol; oral

8.6

307.7

4307

21092

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

13.0

307.7

1458

1535

I42.1

ICD-10 Finland

Obstructive hypertrophic cardiomyopathy

48.1

307.7

243

I47.2

ICD-10 Finland

Ventricular tachycardia

18.6

307.7

736

459

I42.8

ICD-10 Finland

Other cardiomyopathies

49.8

307.7

233

FPE96

NOMESCO Finland

Other implantation or replacement of transvenous cardiac pacemaker

39.6

307.7

277

I50.9

ICD-10 Finland

Heart failure, unspecified

14.8

307.7

3172

5264

I50.1

ICD-10 Finland

Left ventricular failure

25.1

307.7

2127

1435

GD1LA

NOMESCO Finland

12.5

307.7

401

347

K77

ICPC

Heart failure

9.9

307.7

469

517

XF404

NOMESCO Finland

Ambulatory ECG

5.0

307.7

1108

2699

I42.0

ICD-10 Finland

Dilated cardiomyopathy

4503599627370496.0

307.7

4987

C01BD01

ATC

amiodarone; systemic

13.8

307.7

877

757

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

4.9

307.7

2670

9422

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

72.2

307.7

897

151

FPG96

NOMESCO Finland

Other implantation of permanent cardioverter-defibrillator

106.7

307.7

357

I50.0

ICD-10 Finland

Congestive heart failure

10.8

307.7

1785

2448

C09AA05

ATC

ramipril; oral

5.8

307.7

2988

10167

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

10.4

288.7

328

334

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

3.1

283.1

1645

6814

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.9

271.1

3341

20473

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

13.3

255.0

245

193

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.9

251.5

1595

6869

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

3.0

243.4

1462

6096

AP4

Myocardial biopsy

104.2

236.5

122

TFJ02

NOMESCO Finland

Muscle biopsy of heart

47.8

231.4

135

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

7.7

230.0

333

459

FPJ24

NOMESCO Finland

Revision of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

380.5

220.0

220

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

4.3

214.9

606

1547

R06.0

ICD-10 Finland

Dyspnoea

2.6

211.6

1934

9869

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

3.8

208.5

733

2190

4254A

ICD-9 Finland

Cardiomyopathy, Other primary cardiomyopathies

92.0

206.3

108

I42

ICD-10 Finland

Cardiomyopathy

696.3

204.9

201

AS7

Arrhythmia pacemaker insertion VVI (R) S

39.4

201.4

123

XF400

NOMESCO Finland

ECG with 12 standard connections

2.8

200.5

1291

5514

Angiography of the heart and coronary arteries

3.7

199.3

706

2117

M04AA01

ATC

allopurinol; systemic

2.8

198.2

1292

5551

FPG40

NOMESCO Finland

Replacement of pulse generator in transvenous cardioverter-defibrillator

34.2

184.3

117

FM1CG

NOMESCO Finland

Extensive examination of hear with high intensity magnet

20.5

181.0

138

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

4.4

178.1

476

1161

K78

ICPC

Atrial fibrillation/flutter

3.2

172.4

800

2830

I48.2

ICD-10 Finland

Chronic atrial fibrillation

3.8

171.1

563

1598

WX740

NOMESCO Finland

Nitrogen oxide therapy

54.4

168.9

XF640, ,

NOMESCO Finland

5.3

166.7

350

698

FPH10

NOMESCO Finland

Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator

29.1

166.3

111

A10BK03

ATC

empagliflozin; oral

2.9

165.8

937

3698

WX892

NOMESCO Finland

Monitored bed care

3.3

164.0

716

2438

C07AG02

ATC

carvedilol; oral

3.6

163.2

596

1813

AP1

Catheterization of the left side of the heart

7.0

162.4

254

380

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

7.9

162.2

226

297

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

6.3

160.5

277

459

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.3

155.3

1860

10387

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

6.7

151.4

247

386

FXL00

NOMESCO Finland

Insertion and use of extra-, para- or intracorporeal VAD

73.9

148.2

FM1JR

NOMESCO Finland

Heart, extensive metabolic PET with CT

38.6

148.2

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.2

146.1

668

2330

K84

ICPC

Heart disease other

4.5

145.2

372

875

AS8

Physiological arrhythmia pacemaker insertionDDD (R) S

30.2

144.2

TFP47

NOMESCO Finland

Ablation or modification of the AV-node

15.1

143.6

127

C07AA07

ATC

sotalol; systemic

4.1

141.6

412

1067

B01AF02

ATC

apixaban; oral

2.5

140.9

1117

5182

Z2221

NOMESCO Finland

Medical doctor

2.2

140.8

1588

8583

FPE25

NOMESCO Finland

Implantation of biventricular cardiac pacemaker, atrial and ventricular electrodes, CRT-P (DDDR)

27.7

140.0

TFP30

NOMESCO Finland

Cathetric examination for cardiac arrythmia

9.7

139.4

164

174

XF409

NOMESCO Finland

Other special ECG

13.6

134.1

126

ZXE00

NOMESCO Finland

One hour or less

2.1

131.5

2142

13269

I44.2

ICD-10 Finland

Atrioventricular block, complete

4.4

131.5

350

847

ASB

Insertion of a biventricular physiological pacemaker DDD (R)

156.5

130.0

137

A12BA01

ATC

potassium chloride; oral

4.0

129.7

398

1070

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

5.5

129.0

256

484

ZX120

NOMESCO Finland

Intravenous

2.9

128.8

707

2723

ZXD05

NOMESCO Finland

Urgent procedure

2.1

127.4

1770

10305

FPE36

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with ventricular electrodes

44.8

126.6

TFP34

NOMESCO Finland

Electrophysiological investigation

4.5

124.8

322

760

XFE00

NOMESCO Finland

Epicardial ultrasonography

5.0

123.1

275

577

FPE40

NOMESCO Finland

Replacement of transvenous cardiac pacemaker electrode

13.3

118.8

113

127

Kela drug reimbursment

Transplant complication

6.6

117.7

194

306

I48.1

ICD-10 Finland

Persistent atrial fibrillation

3.4

116.3

452

1421

I49.3

ICD-10 Finland

Ventricular premature depolarization

2.9

114.1

583

2153

FQA10

NOMESCO Finland

Orthotopic transplantation of heart with bicaval anastomosis

233.3

111.2

114

M10.9

ICD-10 Finland

Gout, unspecified

2.7

111.0

687

2804

TPH07

NOMESCO Finland

Cathetrisation of artery

2.4

109.2

883

4088

FPJ21

NOMESCO Finland

Revision of cardioverter-defibrillator with ventricular electrode

38.7

105.9

FM1DM

NOMESCO Finland

Heart very extensive MRI examination with 3 Tesla magnet

55.2

105.7

Z3231

NOMESCO Finland

Registered nurse

2.0

96.8

1595

9673

ZXD10

NOMESCO Finland

Scheduled procedure

1.9

93.3

2006

13230

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

3.9

93.1

290

785

FPJ22

NOMESCO Finland

Revision of cardioverter-defibrillator with atrial and ventricular electrodes

24.4

91.6

L04AD02

ATC

tacrolimus; systemic

7.4

91.4

134

186

ATX

Other pacemaker replacement or related action, such as cord removal or replacement

21.5

91.2

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

3.2

90.2

391

1309

I42.6

ICD-10 Finland

Alcoholic cardiomyopathy

26.1

89.6

WX872

NOMESCO Finland

Intensive care

2.9

88.6

457

1688

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.4

87.2

646

2856

I41.8*D86.8

ICD-10 Finland

Sarcoid myocarditis

22.8

86.4

FPE24

NOMESCO Finland

Implantation of biventricular cardiac pacemaker, ventricular electrodes, CRT-P (VVIR)

28.8

85.1

4259X

ICD-9 Finland

Cardiomyopathy, Secondary cardiomyopathy, unspecified

45.9

84.7

Electrophysiological Special Examination

9.5

84.3

100

107

AS6

Biventricular physiological heart failure pacemaker insertion DDD (R)

115.9

84.2

TK800

NOMESCO Finland

Hemodialysis

4.2

82.5

226

557

L04AA06

ATC

mycophenolic acid; systemic

4.9

82.1

185

390

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.2

82.1

857

4371

R02

ICPC

Shortness of breath/dyspnoea

2.2

81.2

839

4260

FXD00

NOMESCO Finland

Use of ECHLA without concurrent surgical procedure

41.2

80.9

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

80.1

1660

10701

R4110

NOMESCO Finland

Physiotherapy

1.8

80.1

1556

9835

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.9

78.9

390

1405

AP2

Catheterization of the right side of the heart

12.4

78.8

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

78.1

1330

8053

FPG42

NOMESCO Finland

Replacement of electrode(s) in transvenous cardioverter-defibrillator

46.4

78.1

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

2.3

78.0

659

3079

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

77.8

1000

5503

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

5.4

77.7

157

301

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.5

76.3

512

2155

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

21.3

76.2

H02AB06

ATC

prednisolone; systemic

1.7

75.0

2492

18296

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

3.4

75.0

284

874

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.8

74.8

1570

10117

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

10.7

74.3

3AC01, ,

NOMESCO Finland

7.1

73.6

111

159

ARB

Catheter ablation of arrhythmia: Cutiing or modification of the AV node

35.7

73.2

TK810

NOMESCO Finland

Hemofiltration

8.0

72.8

126

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.5

72.4

511

2201

B01AB05

ATC

enoxaparin; parenteral

1.8

71.9

1698

11298

XF402

NOMESCO Finland

ECG with work load test

2.2

71.8

711

3538

C07AB02

ATC

metoprolol; systemic

1.9

71.1

1209

7284

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

4.4

69.8

180

423

AP3

Catheterization of the right and left side of the heart

15.0

69.1

E05.89

ICD-10 Finland

Other thyrotoxicosis

14.6

69.0

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

2.6

68.8

420

1686

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

67.7

738

3806

C09AA04

ATC

perindopril; oral

2.7

67.6

387

1504

ZX108

NOMESCO Finland

Inhalation

7.5

67.3

132

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

66.6

1839

12714

TFP35

NOMESCO Finland

Electroanatomical mapping

4.8

65.6

151

324

Initial pacemaker installation

8.6

64.0

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

3.1

63.7

279

937

FPJ00

NOMESCO Finland

Revision of pacemaker pulse generator or electrode

12.5

63.2

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

62.5

1193

7405

I47.1

ICD-10 Finland

Supraventricular tachycardia

3.0

61.3

285

990

Catheterization and pressure measurement of the right side of the heart

10.1

61.1

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.7

61.0

350

1360

C09AA02

ATC

enalapril; systemic

1.8

61.0

1187

7402

A46

ICD-10 Finland

Erysipelas

1.9

60.6

958

5603

I25.2

ICD-10 Finland

Old myocardial infarction

2.2

60.5

535

2534

Z3226

NOMESCO Finland

Physiotherapist

1.9

58.9

957

5641

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.0

58.8

770

4226

3A064, ,

NOMESCO Finland

9.4

57.2

Initial installation of the atrial pacemaker

15.3

57.1

AQ1

Conventional electrophysiological examination

5.2

56.8

118

232

I49.5

ICD-10 Finland

Sick sinus syndrome

2.8

56.2

295

1094

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

3.5

55.7

200

594

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.0

55.1

710

3869

TFP52

NOMESCO Finland

Ablation treatment of ventricular tachycardia due to structural heart defect

24.6

55.0

FPJ23

NOMESCO Finland

Revision of biventricular cardioverter-defibrillator with ventricular electrodes

101.2

54.9

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

3.2

54.4

227

740

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

53.0

1607

11226

7AX01, ,

NOMESCO Finland

85.4

53.0

Z95.8

ICD-10 Finland

Presence of other cardiac and vascular implants and grafts

7.3

52.9

109

M01AE01

ATC

ibuprofen; systemic, rectal

0.6

52.2

3293

37847

Z50.0

ICD-10 Finland

Cardiac rehabilitation

4.7

51.8

122

267

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.9

51.2

255

919

XFP02, ,

NOMESCO Finland

20.1

49.5

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

49.2

1440

9934

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

3.1

48.5

210

700

A10BA02

ATC

metformin; oral

1.6

47.6

1641

11756

M01AH05

ATC

etoricoxib; oral

0.6

47.2

1808

23456

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.2

47.1

422

2002

742, ,

NOMESCO Finland

10.7

47.1

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

2.5

47.0

317

1330

M10.0

ICD-10 Finland

Idiopathic gout

2.5

46.8

299

1223

FL1AC

NOMESCO Finland

Left cardioangiography

3.7

46.1

151

422

E87.5

ICD-10 Finland

Hyperkalaemia

3.4

46.1

167

499

Z2446

NOMESCO Finland

Social worker

2.4

46.1

347

1530

FPH96

NOMESCO Finland

Other removal of cardiac pacemaker or cardioverter-defibrillator

8.1

45.6

WX722

NOMESCO Finland

PEEP

2.4

45.3

324

1396

N18.8

ICD-10 Finland

Other chronic renal failure

3.0

45.2

205

701

R03BB04

ATC

tiotropium bromide; inhalant

1.9

45.2

636

3556

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

4.2

45.2

121

293

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.4

44.8

315

1347

I34.0

ICD-10 Finland

Mitral (valve) insufficiency

4.0

44.7

129

330

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.3

44.4

173

541

H03BB01

ATC

carbimazole; oral

3.0

44.3

203

699

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

43.6

1503

10719

C10AA01

ATC

simvastatin; oral

1.5

43.5

2352

18501

I34.9

ICD-10 Finland

Nonrheumatic mitral valve disorder, unspecified

5.6

42.6

147

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

42.1

929

5924

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.2

41.5

395

1917

C09AA01

ATC

captopril; oral

3.5

41.2

146

430

C01BB02

ATC

mexiletine; systemic

12.6

40.9

M10

ICD-10 Finland

Gout

2.2

40.9

347

1609

R55

ICD-10 Finland

Syncope and collapse

1.8

40.3

639

3702

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

4.0

40.2

114

288

A10BH05

ATC

linagliptin; oral

2.2

39.7

358

1701

I34.1

ICD-10 Finland

Mitral (valve) prolapse

2.9

39.6

196

704

K99

ICPC

Cardiovascular disease other

2.8

39.3

205

757

N19

ICD-10 Finland

Unspecified kidney failure

2.4

39.3

275

1173

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.5

39.2

217

TFP32

NOMESCO Finland

Cathetric treatmen of cardiac arrythmia

6.0

38.9

117

FPJ

NOMESCO Finland

Review and replacement of pacemaker or internal defibrillator device or electrode

10.1

38.9

G04BE03

ATC

sildenafil; oral

3.3

38.8

150

467

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.0

37.8

434

2257

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

37.7

734

4512

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

37.4

492

2682

5AB14, ,

NOMESCO Finland

14.3

37.3

FXF00

NOMESCO Finland

Decannulation after ECHLA or ECLA

61.9

37.1

Catheterization and pressure measurement of the left side of the heart

3.3

36.5

138

424

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.2

36.1

305

1410

FPJ12

NOMESCO Finland

Revision of biventricular CRT-P (DDDR) generator

80.7

35.8

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.6

35.7

1161

8108

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.8

35.5

588

3446

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

35.0

1370

9953

E66.00

ICD-10 Finland

Metabolic syndrome

2.2

34.7

319

1526

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.1

34.4

328

1592

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

34.3

870

5722

E66.8

ICD-10 Finland

Other obesity

2.4

34.2

237

1006

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.9

34.2

159

552

FN1CD

NOMESCO Finland

Very extensive CT of coronary arteries

6.2

33.9

FPW96

NOMESCO Finland

Other operation for arhythmia or disturbance of impulse propagation

6.2

33.9

Cardiac muscle biopsy

76.7

33.8

ASA

Insertion of a biventricular pacemaker VVI (R) S

76.7

33.8

AK1

HTX (heart transplant)

+∞

33.4

I45.9

ICD-10 Finland

Conduction disorder, unspecified

4.5

33.3

182

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.1

33.3

346

1735

R03AC02

ATC

salbutamol; inhalant

1.4

33.2

2378

19372

T90

ICPC

Diabetes non-insulin dependent

1.5

33.2

1368

10028

J01FF01

ATC

clindamycin; systemic

1.5

33.2

1282

9272

I44.6

ICD-10 Finland

Other and unspecified fascicular block

12.9

33.1

I47.0

ICD-10 Finland

Re-entry ventricular arrhythmia

10.7

33.1

E66.01

ICD-10 Finland

Obesity due to excess calories

2.0

33.1

379

1968

FXE00

NOMESCO Finland

Use of ECLA

63.8

33.0

AA1AD

NOMESCO Finland

CT of head and brain

1.5

32.9

1550

11668

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

3.7

32.8

104

285

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.4

32.7

232

995

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.2

32.7

289

1361

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.7

32.3

668

4161

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.7

32.3

609

3699

Catheter ablation of arrhythmia

6.1

31.8

FQA00

NOMESCO Finland

Orthotopic transplantation of heart

114.1

31.7

WX882

NOMESCO Finland

High dependency care

2.6

31.4

185

727

XF600

NOMESCO Finland

Bloodpressure measurement

2.0

31.3

360

1871

AS5

Biventricular heart failure pacemaker insertion VVI (R)

53.2

31.3

I42.7

ICD-10 Finland

Cardiomyopathy due to drugs and other external agents

60.4

31.1

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.3

31.0

246

1107

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.1

31.0

308

1517

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

3.1

30.8

128

417

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.8

30.2

159

590

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

3.1

29.8

125

409

TFC20

NOMESCO Finland

Catheterisation of both sides of heart

9.5

29.7

XF622

NOMESCO Finland

Measurement of minute volume of heart

7.2

29.6

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.1

29.6

309

1551

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

5.4

29.4

109

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.1

29.2

290

1429

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.8

29.1

507

3006

FXM00

NOMESCO Finland

Removal of extra-, para- or intracorporeal VAD

66.3

28.9

WX902

NOMESCO Finland

External defibrillation of heart

6.1

28.9

TKC20

NOMESCO Finland

Catheterisation of bladder

1.8

28.7

421

2372

T92

ICPC

Gout

2.6

28.3

170

675

R2110

NOMESCO Finland

Giving the first information

2.1

28.2

261

1251

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.0

28.2

309

1578

N17.8

ICD-10 Finland

Other acute renal failure

3.3

28.2

107

330

A10AE04

ATC

insulin glargine; parenteral

1.7

28.2

547

3344

S97

ICPC

Chronic ulcer skin

1.9

28.1

383

2106

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

3.3

27.9

104

317

A11CC03

ATC

alfacalcidol; systemic

2.7

27.8

157

604

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

3.0

27.7

126

432

A41.9

ICD-10 Finland

Sepsis, unspecified

2.3

27.7

221

998

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.5

27.5

1055

7576

WX730

NOMESCO Finland

Conventional respirator

3.2

27.3

110

352

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.2

27.2

246

1169

WX930

NOMESCO Finland

Thepapeutic hypothermia

9.0

26.8

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.6

26.8

156

610

C09CA03

ATC

valsartan; oral

1.7

26.7

519

3173

XF614

NOMESCO Finland

Measurement of pulmonary artery pressure

8.6

26.6

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.0

26.6

296

1520

K83

ICPC

Heart valve disease NOS

3.5

26.6

258

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.2

26.4

215

979

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

25.8

831

5741

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.8

25.7

379

2137

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

25.2

545

3425

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

25.1

1193

8908

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.2

25.0

219

1028

I51.7

ICD-10 Finland

Cardiomegaly

5.9

24.8

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

24.7

307

1637

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.6

24.4

534

8142

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.1

24.1

239

1176

H02AB07

ATC

prednisone; oral

1.6

23.7

603

3941

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.0

23.6

277

1448

R18

ICD-10 Finland

Ascites

2.8

23.6

122

449

AS4

Physiological pacemaker insertion DDD (R)

3.1

23.5

315

C10AA05

ATC

atorvastatin; oral

1.4

23.5

2244

18777

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.9

23.3

280

1477

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

23.2

280

1478

C08DA01

ATC

verapamil; systemic

2.2

23.1

209

994

R4190

NOMESCO Finland

Nutritional therapy

2.2

23.0

192

883

C01BA03

ATC

disopyramide; systemic

4.6

22.8

119

I46.9

ICD-10 Finland

Cardiac arrest, unspecified

5.1

22.8

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

2.9

22.8

108

380

WX213

NOMESCO Finland

Lower leg blockade

3.9

22.6

171

C03AA03

ATC

hydrochlorothiazide; oral

1.7

22.6

449

2757

C01DA14

ATC

isosorbide mononitrate; oral

1.5

22.5

902

6500

J01MA12

ATC

levofloxacin; systemic

1.5

22.4

933

6775

ZX197, ,

NOMESCO Finland

32.4

22.4

RS221, ,

NOMESCO Finland

3.4

22.4

238

R04.0

ICD-10 Finland

Epistaxis

1.7

22.2

419

2537

AS2

Ventricular pacemaker insertion VVI (R)

4.2

22.1

139

A10BH01

ATC

sitagliptin; oral

1.6

21.9

522

3356

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.2

21.8

195

922

R04.2

ICD-10 Finland

Haemoptysis

2.1

21.8

224

1118

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.9

21.7

103

363

A10BJ06

ATC

semaglutide; parenteral

1.9

21.7

274

1470

J01MA14

ATC

moxifloxacin; systemic

1.7

21.5

445

2759

C01BA01

ATC

quinidine; oral

4.4

21.5

125

WW200

NOMESCO Finland

Immunization

2.4

21.5

147

621

J81

ICD-10 Finland

Pulmonary oedema

4.8

21.5

101

FXG00

NOMESCO Finland

Insertion and use of IABP

6.4

21.3

I42.5

ICD-10 Finland

Other restrictive cardiomyopathy

26.5

21.3

N05CF01

ATC

zopiclone; oral

1.4

21.0

1427

11274

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

21.0

362

2137

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.0

21.0

232

1189

B01AF01

ATC

rivaroxaban; oral

1.5

20.9

659

4515

WX002

NOMESCO Finland

Sedation and analgesia

1.5

20.7

882

6421

B01AE07

ATC

dabigatran etexilate; oral

2.0

20.5

222

1128

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

20.5

302

1700

3A149, ,

NOMESCO Finland

30.2

20.5

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

3.8

20.5

165

FPG04

NOMESCO Finland

Insertion of internal defibrillator, atrial and chamber electrode

22.4

20.3

D64.9

ICD-10 Finland

Anaemia, unspecified

1.5

20.2

595

4016

K29

ICPC

Cardiovascular sympt/complt other

1.9

19.8

250

1340

120, ,

NOMESCO Finland

35.9

19.8

A10BJ02

ATC

liraglutide; parenteral

2.3

19.7

145

633

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.4

19.6

141

609

E86

ICD-10 Finland

Volume depletion

2.3

19.6

148

653

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.5

19.6

122

494

283

Kela drug reimbursment

Ivabradine

200.8

19.6

J01DB01

ATC

cefalexin; oral

1.4

19.4

3815

35050

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

3.5

19.3

191

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

3.0

19.3

282

A10AB05

ATC

insulin aspart; parenteral

1.7

19.3

389

2395

J01CA04

ATC

amoxicillin; systemic

1.4

19.2

3606

32858

C01EB17

ATC

ivabradine; oral

46.2

19.2

FA1AC

NOMESCO Finland

Upper cavography

26.1

19.1

GAE10

NOMESCO Finland

Closure of previous incision of chest wall

22.6

19.0

XA800

NOMESCO Finland

Neuropsychological investigation

2.0

19.0

206

1049

M10.3

ICD-10 Finland

Gout due to impairment of renal function

4.7

18.9

XF406

NOMESCO Finland

High resolution ECG

34.4

18.9

I44.1

ICD-10 Finland

Atrioventricular block, second degree

2.3

18.8

144

640

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

2.0

18.7

204

1040

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

18.7

840

6167

C01BC04

ATC

flecainide; systemic

2.1

18.6

185

912

212

Kela drug reimbursment

Gout

2.3

18.5

139

613

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.7

18.5

373

2297

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.0

18.3

197

1000

A02BC02

ATC

pantoprazole; systemic

1.3

18.3

3160

28334

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

18.2

548

3711

I95.9

ICD-10 Finland

Hypotension, unspecified

2.6

18.2

104

404

L04AA01

ATC

[U] ciclosporin

3.2

18.1

229

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.7

18.1

375

2324

SPAT1263

SPAT

Sampling

1.3

18.1

1756

14553

B01AF03

ATC

edoxaban; oral

2.3

18.0

139

620

WX900

NOMESCO Finland

Resuscitation

4.8

18.0

I51.4

ICD-10 Finland

Myocarditis, unspecified

4.5

18.0

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.0

17.8

191

969

M01AB05

ATC

diclofenac; systemic, rectal

0.8

17.7

2270

25945

L04AX01

ATC

azathioprine; systemic

2.0

17.5

181

905

FN1AD

NOMESCO Finland

CT of coronary arteries

2.6

17.5

383

4251A

ICD-9 Finland

Cardiomyopathy, Hypertrophic obstructive cardiomyopathy

28.9

17.4

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

17.3

615

4312

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

4.5

17.3

C02EA01, ,

ATC

3.0

17.2

242

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.6

17.1

473

3142

A10BB12

ATC

glimepiride; oral

1.6

17.1

374

2350

G47.3

ICD-10 Finland

Sleep apnoea

1.4

17.1

1149

9011

XX3BW, ,

NOMESCO Finland

31.6

17.0

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.0

17.0

190

978

4289X

ICD-9 Finland

Heart failure, unspecified

5.1

16.9

B01AB04

ATC

dalteparin; parenteral

1.8

16.8

239

1331

FPF00

NOMESCO Finland

Implantation of epicardial pacemaker with ventricular electrode

21.9

16.8

ATB

Replacement of biventricular, physiological pacemaker DDD (R) S

+∞

16.7

FPE26

NOMESCO Finland

Implantation of permanent biventricular pacemaker, transvenous route

+∞

16.7

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

6.5

16.6

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.2

16.6

144

674

WX890

NOMESCO Finland

Intesive care monitoring

3.8

16.6

133

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.0

16.6

191

994

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

1.8

16.5

276

1613

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.9

16.5

275

I41.8

ICD-10 Finland

Myocarditis in other diseases classified elsewhere

27.6

16.5

AT7

Replacing the pacemaker VVI (R) S

27.6

16.5

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

16.3

692

5016

TFP59

NOMESCO Finland

Ablation treatment of other ventricular tachycardia

14.3

16.3

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.3

16.2

121

532

FPH00

NOMESCO Finland

Transvenous extraction of transvenous cardiac pacemaker or cardioverter-defibrillator

12.8

16.1

AQ2

Electrophysiological electroanatomical examination

4.1

16.0

105

I20.00

ICD-10 Finland

Unstable angina

2.0

16.0

170

859

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.1

16.0

145

691

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

3.3

15.8

181

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.7

15.8

321

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

15.7

1349

10942

2BD01, ,

NOMESCO Finland

7.2

15.7

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.3

15.6

120

535

ZY000

NOMESCO Finland

Hospital inpatient

3.3

15.5

178

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.9

15.5

198

1066

T86.2

ICD-10 Finland

Heart transplant failure and rejection

160.5

15.5

OAB43, ,

SPAT

0.6

15.5

414

6099

K28

ICPC

Limited function/disability (K)

2.2

15.4

130

603

M01AC06

ATC

meloxicam; systemic, rectal

0.7

15.4

952

12088

C02EA02, ,

ATC

1.8

15.4

231

1310

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.9

15.3

193

1035

FKD00

NOMESCO Finland

Replacement of mitral valve using mechanical prosthesis

6.7

15.3

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.9

15.2

193

1037

288

Kela drug reimbursment

Febuxostat

4.3

15.2

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

15.2

638

4614

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.9

15.2

201

1096

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.9

15.0

176

921

I40.0

ICD-10 Finland

Infective myocarditis

14.0

15.0

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

1.9

15.0

196

1065

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

14.9

1716

14450

I40.9

ICD-10 Finland

Acute myocarditis, unspecified

4.0

14.8

107

SPAT1255

SPAT

Intravenous administration of medicine

1.6

14.8

326

2054

XG466

NOMESCO Finland

Sleep oxymetry

2.0

14.7

159

809

SPAT1325

SPAT

Vaccination

1.3

14.7

1460

12057

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.3

14.7

1326

10812

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

14.7

307

1907

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.5

14.6

537

3785

C08DB01

ATC

diltiazem; oral

1.7

14.5

252

1490

4276B

ICD-9 Finland

Cardiac dysrhythmias, Premature beats[EXTRASYSTOLIA VENTRICULARIS]

4.8

14.5

5CM18, ,

NOMESCO Finland

4.5

14.5

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

14.4

289

1777

GD1AD

NOMESCO Finland

Thorax CT examination

1.6

14.3

326

2071

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.2

14.3

124

582

3058, ,

Kela drug reimbursment

27.2

14.3

XF620

NOMESCO Finland

Examination of circulation with color method

4.7

14.2

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

14.2

1852

15815

C07AB03

ATC

atenolol; systemic

1.7

14.2

280

1714

J96.0

ICD-10 Finland

Acute respiratory failure

2.6

14.2

304

GE1BE

NOMESCO Finland

Mediastinal ultrasound examinaiton through oesophagus

6.4

14.1

K60

ICPC

Cardiovascular, Result test/procedure

3.3

14.1

154

42792

ICD-8 Finland

Symptomatic heart disease, Fibrillatio auricularis

3.3

14.1

159

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.5

14.0

399

2666

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.5

14.0

531

3763

4271A

ICD-9 Finland

Cardiac dysrhythmias, Paroxysmal ventricular tachycardia

6.7

14.0

I51.3

ICD-10 Finland

Intracardiac thrombosis, not elsewhere classified

10.9

14.0

I95.2

ICD-10 Finland

Hypotension due to drugs

3.2

13.9

165

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.8

13.9

212

1209

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

13.8

301

1890

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

2.4

13.8

368

G93.1

ICD-10 Finland

Anoxic brain damage, not elsewhere classified

4.4

13.8

TFN04, ,

NOMESCO Finland

3.9

13.7

104

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

1.7

13.7

230

1347

K85

ICPC

Elevated blood pressure

0.7

13.7

390

5681

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.7

13.6

261

1585

A10AC01

ATC

insulin (human); parenteral

1.6

13.6

343

2230

R50.9

ICD-10 Finland

Fever, unspecified

1.4

13.6

673

5004

TFP44

NOMESCO Finland

Ablation treatment of typical atrial flutter

2.9

13.6

220

I42.3

ICD-10 Finland

Endomyocardial (eosinophilic) disease

75.3

13.6

Z31.5

ICD-10 Finland

Genetic counselling

2.0

13.5

151

778

AJ1

Reconstruction of the aortic base, eg composite graft, incl. valve saving operation

5.9

13.5

E66.9

ICD-10 Finland

Obesity, unspecified

2.0

13.5

137

683

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.0

13.5

144

731

AR8

Catheter ablation of arrhythmia, target: left ventricular tachycardia

18.2

13.3

FM1CD

NOMESCO Finland

Very extensive CT of heart

5.0

13.3

160

Kela drug reimbursment

exenatide

2.3

13.3

102

455

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

13.3

1569

13213

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.3

13.2

412

D86.0

ICD-10 Finland

Sarcoidosis of lung

2.9

13.2

218

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

2.5

13.2

315

Z01.8

ICD-10 Finland

Other specified special examinations

1.3

13.2

962

7600

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.4

13.2

780

5972

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

13.1

1244

10183

FK1BT

NOMESCO Finland

Implantation of cardiac pacemaker with X-ray guidance

4.2

13.1

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.7

13.1

255

1556

L04AD01

ATC

ciclosporin; systemic

2.5

13.0

341

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

2.7

12.9

243

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

12.9

1896

16366

I48.4

ICD-10 Finland

Atypical atrial flutter

3.5

12.9

123

FKD10

NOMESCO Finland

Replacement of mitral valve using biological prosthesis

4.0

12.9

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

12.8

1297

10703

M13.9

ICD-10 Finland

Arthritis, unspecified

1.6

12.8

305

1957

Q21.10

ICD-10 Finland

Persistent ostium secundum

5.8

12.7

I24.0

ICD-10 Finland

Coronary thrombosis not resulting in myocardial infarction

9.7

12.7

N18.0

ICD-10 Finland

End-stage renal disease

2.7

12.7

240

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.7

12.7

255

1570

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

3.0

12.6

191

TFC99

NOMESCO Finland

Catheterisation of heart with other procedure

12.3

12.6

RS222, ,

NOMESCO Finland

2.9

12.6

197

FKC61

NOMESCO Finland

Repair of mitral valve insufficiency by a transluminally inserted clip

32.1

12.6

E06.4

ICD-10 Finland

Drug-induced thyroiditis

17.3

12.5

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

3.7

12.5

107

FM1BG

NOMESCO Finland

MRI examination of heart with high intensity magnet

24.4

12.4

FJA00

NOMESCO Finland

Biopsy of right ventricle

130.3

12.4

FPJ11

NOMESCO Finland

Revision of biventricular CRT-P (VVIR) generator

130.3

12.4

AT6

Biventricular physiological heart failure pacemaker replacement DDD (R)

130.3

12.4

A07AA02

ATC

nystatin; oral

1.7

12.4

230

1387

I20.09

ICD-10 Finland

Unstable angina

1.6

12.3

299

1927

I11

ICD-10 Finland

Hypertensive heart disease

3.4

12.3

127

M04AA03

ATC

febuxostat; oral

4.1

12.3

OAA67, ,

SPAT

0.6

12.2

215

3496

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.6

12.2

255

1584

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

4.0

12.2

ZXD00

NOMESCO Finland

Emergency procedure

1.9

11.9

142

749

TFP51

NOMESCO Finland

Ablation treatment of idiopathic left ventricle tachycardia

13.4

11.9

Z95.9

ICD-10 Finland

Presence of cardiac and vascular implant and graft, unspecified

4.4

11.9

FGC10

NOMESCO Finland

Annuloplasty of tricuspid valve using prosthetic ring

4.4

11.9

Z2445

NOMESCO Finland

Psychologist

2.0

11.9

135

701

TPX10

NOMESCO Finland

Implantation of vascular injection port

1.9

11.8

139

730

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

1.9

11.8

146

780

ZXE90

NOMESCO Finland

More than 22 hours

3.4

11.8

121

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

3.3

11.7

131

FPH20

NOMESCO Finland

Removal of epicardial pacemaker or cardioverter-defibrillator

30.1

11.6

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

11.6

1090

8892

ATA

Biventricular pacemaker replacement VVI (R) S

65.1

11.6

Z71.8

ICD-10 Finland

Other specified counselling

1.3

11.5

1311

10952

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

11.5

443

3147

354

Kela drug reimbursment

Ivabradine

+∞

11.5

Z94.3

ICD-10 Finland

Heart and lungs transplant status

+∞

11.5

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

2.9

11.4

175

N02AX02

ATC

tramadol; systemic, rectal

1.2

11.3

1946

17021

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

11.3

1372

11546

N40

ICD-10 Finland

Hyperplasia of prostate

0.8

11.2

1080

13036

JN4DR

NOMESCO Finland

Whole body metabolic PET with CT

9.6

11.2

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

3.2

11.2

135

ZXA05

NOMESCO Finland

Left side

1.3

11.1

1039

8463

SPAT1254

SPAT

Administration of medicine

1.4

11.1

616

4658

257, ,

Kela drug reimbursment

25.1

11.1

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

1.9

11.0

135

719

R1420

NOMESCO Finland

Assessment of rehabilitation needs and/or compilation of rehabilitation plan

8.6

11.0

FPJ04

NOMESCO Finland

Revision of pacemaker generator with atrial and ventricular electrodes

3.5

11.0

102

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

2.7

11.0

224

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

2.7

10.9

219

J96.1

ICD-10 Finland

Chronic respiratory failure

2.0

10.8

113

570

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

0.3

10.7

847

4148X

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Other specified forms of chronic ischaemic heart disease[MORBUS CORDIS ISCHAEMICUS ALIA,MÄÄRITTELEMÄT]

3.6

10.7

C01DX22

ATC

vericiguat; systemic

28.1

10.7

SPAT1285

SPAT

Provision of consultation response

1.7

10.7

213

1309

NHQ40

NOMESCO Finland

Amputation of toe

2.1

10.6

439

J94.8

ICD-10 Finland

Other specified pleural conditions

2.2

10.6

400

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

2.7

10.5

200

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.9

10.5

132

710

Z82.4

ICD-10 Finland

Family history of ischaemic heart disease and other diseases of the circulatory system

4.4

10.5

KA1AE

NOMESCO Finland

Kidney ultrasound examination

1.9

10.5

128

682

R4120

NOMESCO Finland

Occupational therapy

1.6

10.5

268

1750

FM1BD

NOMESCO Finland

Extensive CT of heart

4.5

10.5

A12AA04

ATC

calcium carbonate; oral

2.3

10.5

358

G04BD12

ATC

mirabegron; oral

0.7

10.4

277

4103

JN4AD

NOMESCO Finland

Body CT examination

1.4

10.4

568

4284

5244

FHL

Heart transplantation

110.3

10.4

AM4

VAD (use of the left and / or right side mechanical support (other than IABP)

110.3

10.4

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

3.2

10.4

126

349

Kela drug reimbursment

Febuxostat

3.9

10.4

FM1CN

NOMESCO Finland

Heart perfusion isotope imaging at rest

12.0

10.3

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

1.7

10.3

196

1191

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.9

10.3

130

701

R94.2

ICD-10 Finland

Abnormal results of pulmonary function studies

3.2

10.3

127

SPAT1260

SPAT

Consultation of another employee

1.3

10.3

693

5399

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

2.7

10.2

192

M03BX02

ATC

tizanidine; oral

0.8

10.1

2012

22522

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

2.1

10.1

409

N02BE01

ATC

paracetamol; systemic, rectal

1.3

10.1

4122

39257

I13.2

ICD-10 Finland

Hypertensive heart and renal disease with both (congestive) heart failure and renal failure

4.0

10.0

B03XA02

ATC

darbepoetin alfa; parenteral

2.0

10.0

111

573

FM1EE, ,

SPAT

2.4

10.0

277

T82.7

ICD-10 Finland

Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts

4.8

10.0

O99.4

ICD-10 Finland

Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium

10.0

FKC96

NOMESCO Finland

Other repair of mitral valve for insufficiency

4.6

10.0

TK830

NOMESCO Finland

Ultrafiltration

14.6

10.0

J01DA01

ATC

[U] cefalexin

1.2

10.0

2567

23277

S18

ICPC

Laceration/cut

1.2

9.9

2160

19266

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.5

9.9

305

2073

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

2.6

9.8

219

G71.08

ICD-10 Finland

Other muscular dystrophy

12.2

9.8

3A422, ,

NOMESCO Finland

12.2

9.8

3AE00, ,

NOMESCO Finland

26.1

9.8

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.4

9.8

507

3792

JN3AD

NOMESCO Finland

Abdominal CT examination

1.3

9.8

588

4501

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.0

9.8

488

FM1AD

NOMESCO Finland

CT of heart

4.0

9.8

FCA60

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of composite graft with mechanical valve prosthesis

4.0

9.8

RS230, ,

NOMESCO Finland

3.5

9.8

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.4

9.7

391

2799

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.8

9.7

143

809

A10BX07

ATC

[U] liraglutide

2.4

9.7

257

J01FA06

ATC

roxithromycin; oral

1.2

9.6

1549

13396

A10AE05

ATC

insulin detemir; parenteral

1.6

9.5

231

1490

FN1BD

NOMESCO Finland

Extensive CT of coronary arteries

9.1

9.5

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

2.5

9.5

229

PA2VT

NOMESCO Finland

Intravascular evacuation of brain artery embolus

3.1

9.5

128

C08CA01

ATC

amlodipine; oral

0.8

9.5

1434

16529

3025

Kela drug reimbursment

Calcium carbonate

3.1

9.5

123

FPB22

NOMESCO Finland

Transvenous radiofrequency ablation of aberrant pathway or focus of heart

4.1

9.4

G04CA01

ATC

alfuzosin; oral

0.7

9.4

504

6600

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

9.3

334

2340

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

2.3

9.3

305

42700

ICD-8 Finland

Symptomatic heart disease, Congestive heart failure

4.9

9.3

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.4

9.3

375

2689

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

2.1

9.2

397

XG410

NOMESCO Finland

Flow-volume spirometry

1.7

9.2

172

1040

I71.9

ICD-10 Finland

Aortic aneurysm of unspecified site, without mention of rupture

2.1

9.2

384

ZYC01

NOMESCO Finland

Remote contact by phone

1.6

9.2

234

1527

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.4

9.2

364

2600

D75.1

ICD-10 Finland

Secondary polycythaemia

3.0

9.1

131

SPAT1252

SPAT

Overall medication plan or its review

1.5

9.1

293

2013

FM1DE, ,

SPAT

3.5

9.1

I49.2

ICD-10 Finland

Junctional premature depolarization

4.8

9.1

ASX

Other pacemaker insertion

11.5

9.1

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.8

9.0

790

9689

474, ,

NOMESCO Finland

15.6

9.0

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.0

9.0

469

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

2.6

9.0

188

0034, ,

NOMESCO Finland

24.0

8.9

E66.0

ICD-10 Finland

Obesity due to excess calories

2.6

8.9

189

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

8.9

732

5854

I45.3

ICD-10 Finland

Trifascicular block

3.2

8.9

107

C10AA03

ATC

pravastatin; oral

1.5

8.9

321

2255

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

2.4

8.9

237

M10.2

ICD-10 Finland

Drug-induced gout

4.3

8.9

FWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of heart and major thoracic vessels

12.5

8.9

132

Kela drug reimbursment

Sarcoidosis

3.0

8.8

123

L28

ICPC

Limited function/disability (L)

1.3

8.8

830

6752

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

2.2

8.8

326

J45.8

ICD-10 Finland

Mixed asthma

1.8

8.8

117

643

R03BA02

ATC

budesonide; inhalant

1.3

8.8

627

4920

R03AC03

ATC

terbutaline; inhalant

1.4

8.7

468

3518

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

2.0

8.7

433

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

2.6

8.7

197

WX110

NOMESCO Finland

Infiltration anesthesia

1.2

8.7

3026

28058

C61

ICD-10 Finland

Malignant neoplasm of prostate

0.7

8.7

357

4877

162

Kela drug reimbursment

liraglutide

2.4

8.6

228

R03.0

ICD-10 Finland

Elevated blood-pressure reading, without diagnosis of hypertension

0.4

8.6

995

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.5

8.5

286

1979

TFP50

NOMESCO Finland

Ablation treatment of idiopathic right ventricle tachycardia

9.0

8.5

SPAT1262

SPAT

Handing over of treatment supplies

1.3

8.5

796

6467

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

1.9

8.5

107

578

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.5

8.5

276

1900

RS220, ,

NOMESCO Finland

2.5

8.4

212

42798

ICD-8 Finland

Symptomatic heart disease, Alia arrhytmia definita

2.9

8.4

132

I45.2

ICD-10 Finland

Bifascicular block

3.0

8.4

116

FEB10

NOMESCO Finland

Decompression and drainage of pericardium

3.6

8.4

OAA80, ,

SPAT

0.6

8.4

137

2266

A41.8

ICD-10 Finland

Other specified sepsis

1.9

8.4

517

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

8.3

397

2928

K08.3

ICD-10 Finland

Retained dental root

1.4

8.3

355

2570

L82

ICD-10 Finland

Seborrhoeic keratosis

0.7

8.3

480

6226

XX9XB

NOMESCO Finland

Other X-ray examination with contrast

4.0

8.3

SPAT1251

SPAT

Organisation of medication

1.7

8.3

137

803

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.8

8.3

109

597

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

0.6

8.3

184

2831

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.6

8.3

186

1181

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

0.7

8.2

339

4634

FM2CE, ,

NOMESCO Finland

7.1

8.2

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

1.9

8.2

102

548

AA1

Conventional CABG

1.8

8.2

110

606

205

Kela drug reimbursment

Chronic hypertension

1.2

8.2

1302

11209

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.4

8.2

307

2172

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.3

8.1

631

5003

GBB00

NOMESCO Finland

Tracheostomy

2.3

8.1

247

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.5

8.1

224

1491

S76

ICPC

Skin infection other

1.5

8.1

230

1540

EB1WA, ,

NOMESCO Finland

3.1

8.1

103

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

8.1

401

2979

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

2.4

8.1

229

C09DA01

ATC

losartan and diuretics; oral

0.7

8.1

250

3594

R11

ICD-10 Finland

Nausea and vomiting

1.4

8.1

304

2153

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

2.1

8.0

332

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

8.0

752

6112

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

2.2

8.0

300

K22

ICPC

Risk factor cardiovascular disease

1.5

8.0

265

1832

ZYC03

NOMESCO Finland

Remote contact, text-based

3.1

8.0

104

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

2.9

7.9

120

GD2SN

NOMESCO Finland

Lung ventilation SPECT

2.8

7.9

142

M01AE02

ATC

naproxen; oral, rectal

0.8

7.9

1794

20015

SPAT1281

SPAT

Other administrative function

1.4

7.9

287

2018

FN1BE

NOMESCO Finland

Ultrasound examination of coronary arteries through catheter

2.5

7.9

201

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

1.7

7.9

124

718

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.6

7.8

157

969

J42

ICD-10 Finland

Unspecified chronic bronchitis

2.3

7.8

251

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

1.8

7.8

121

697

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.3

7.8

478

3668

FKE60

NOMESCO Finland

Repair of mitral valve regurgitation with transvenously implanted clip

10.8

7.8

4240A

ICD-9 Finland

Other diseases of endocardium, Mitral valve disorders[INSUFFICIENTIA VALVULAE MITRALIS (NON RHEUMATICA)]

9.4

7.8

XFN00

NOMESCO Finland

Inside imaging of coronary arteries??

2.7

7.7

144

G04CA52

ATC

tamsulosin and dutasteride; systemic

0.7

7.7

411

5397

G71.0

ICD-10 Finland

Muscular dystrophy

45.0

7.7

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

1.8

7.7

113

641

J46

ICD-10 Finland

Status asthmaticus

1.9

7.7

525

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

2.6

7.7

162

TGC00

NOMESCO Finland

Bronchial lavation

1.8

7.7

117

671

A08

ICPC

Swelling

1.5

7.7

233

1583

TFN99

NOMESCO Finland

Catheterisation of heart with other coronary procedure

4.5

7.6

PD5BD

NOMESCO Finland

Extensive CT of aorta

1.9

7.6

527

R5140

NOMESCO Finland

Monitoring the use of the aid

1.3

7.6

507

3939

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.7

7.6

134

801

J20

ICD-10 Finland

Acute bronchitis

1.4

7.6

359

2647

AT8

Physiological pacemaker replacement DDD (R) S

25.0

7.6

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.8

7.6

102

564

T82.1

ICD-10 Finland

Mechanical complication of cardiac electronic device

10.0

7.5

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

7.5

2774

25689

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

2.1

7.4

322

D01BA02

ATC

terbinafine; oral

0.8

7.4

824

9862

Heart transplantation

80.2

7.4

42500

ICD-8 Finland

Cardiomyopathy, Stenosis subaortae hypertrophicans

80.2

7.4

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

3.7

7.3

H02AB04

ATC

methylprednisolone; systemic

1.3

7.3

525

4119

FM1DP

NOMESCO Finland

Heart, metabolic PET

+∞

7.3

G71.06

ICD-10 Finland

Muscular dystrophy severe [Duchenne]

+∞

7.3

FCA70

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of biological valve prosthesis and tube graft

3.6

7.3

FKB10

NOMESCO Finland

Annuloplasty of mitral valve for insufficiency using ring

2.3

7.2

222

K80

ICPC

Cardiac arrhythmia NOS

1.4

7.2

338

2488

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.6

7.2

170

1094

R57.0

ICD-10 Finland

Cardiogenic shock

7.3

7.2

ECB00

NOMESCO Finland

Suture of gingiva

1.6

7.2

151

945

I42.4

ICD-10 Finland

Endocardial fibroelastosis

30.0

7.1

3A560, ,

NOMESCO Finland

7.9

7.1

FKC20

NOMESCO Finland

Plastic repair of mitral valve leaflet for insufficiency

4.1

7.1

EBA00

NOMESCO Finland

Extraction of tooth

1.2

7.1

1472

12970

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

0.8

7.0

1281

14610

ZXF99

NOMESCO Finland

Other r3eason to interrupt procedure

3.0

7.0

N05CD07

ATC

temazepam; oral

1.3

7.0

465

3609

114

Kela drug reimbursment

Glaucoma

0.7

7.0

191

2813

A49

ICD-10 Finland

Bacterial infection of unspecified site

3.5

7.0

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

1.7

7.0

124

744

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

6.9

1608

14296

42509

ICD-8 Finland

Cardiomyopathy, Unspecified

7.5

6.9

A98

ICPC

Health maint/preventive medicine

0.8

6.9

4207

43398

I44.0

ICD-10 Finland

Atrioventricular block, first degree

1.9

6.9

437

ZXD35

NOMESCO Finland

Usual procedure

1.7

6.8

123

740

EB4VA, ,

NOMESCO Finland

0.7

6.8

316

4238

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.6

6.8

143

895

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.1

6.8

280

WW200, ,

SPAT

0.8

6.8

913

10724

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.0

6.8

327

S82

ICPC

Naevus/mole

0.7

6.8

299

4040

R02

ICD-10 Finland

Gangrene, not elsewhere classified

3.6

6.7

X57

ICD-10 Finland

Unspecified privation

1.8

6.7

490

ZZA00

NOMESCO Finland

Split skin graft

1.7

6.7

124

751

K06.18

ICD-10 Finland

Another gingival hyperplasia

3.5

6.7

I44.4

ICD-10 Finland

Left anterior fascicular block

3.9

6.7

SPAT1211

SPAT

Application of soft bandage

1.4

6.7

323

2390

SPAT1081

SPAT

Cardiorespiratory global assessment

1.5

6.7

227

1578

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.5

6.7

1423

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

6.7

2078

18906

G71.00

ICD-10 Finland

Muscular dystrophy benign [Becker]

22.5

6.7

V03AE02

ATC

sevelamer; oral

2.9

6.6

105

A10BJ05

ATC

dulaglutide; parenteral

1.9

6.6

457

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

1.5

6.6

196

1327

W0X00

NOMESCO Finland

Estimation of continuous need for medical therapy

5.5

6.6

OAB48, ,

SPAT

0.7

6.6

227

3199

J01AA02

ATC

doxycycline; systemic

1.2

6.6

3396

32132

130

Kela drug reimbursment

Malignant tumour

0.7

6.6

241

3360

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

2.0

6.5

325

AR5

Catheter ablation of arrhythmia, target: atrial flutter

3.3

6.5

R4130

NOMESCO Finland

Speech therapy

1.7

6.5

111

658

NG1BG, ,

SPAT

0.4

6.5

699

V03AE01

ATC

polystyrene sulfonate; oral

2.0

6.5

346

GD1UN

NOMESCO Finland

Lung circulation SPECT

2.7

6.5

117

A28

ICPC

Limited function/disability NOS

1.2

6.5

802

6713

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.0

6.5

306

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

0.6

6.4

1381

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

3.9

6.4

QDH00

NOMESCO Finland

Avulsion of toe nail

3.9

6.4

221

MVR mechanical

69.9

6.4

G71.03

ICD-10 Finland

Muscular dystrophy autosomal recessive, childhood type, resembling Duchenne or Becker

69.9

6.4

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

2.2

6.4

247

R23.8

ICD-10 Finland

Other and unspecified skin changes

0.8

6.4

587

7187

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

3.3

6.4

3A077, ,

NOMESCO Finland

7.4

6.4

F1279, ,

NOMESCO Finland

7.4

6.4

ZXC96

NOMESCO Finland

Robot assisted procedure

0.4

6.4

778

NA3BG, ,

SPAT

0.4

6.4

861

SPAT1060

SPAT

Administration of oxygen

3.0

6.4

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.5

6.4

181

1215

H13

ICPC

Plugged feeling ear

0.8

6.3

612

7445

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

2.1

6.3

262

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

2.1

6.3

282

R06.2

ICD-10 Finland

Wheezing

1.6

6.3

157

1024

J01MA01

ATC

ofloxacin; systemic

1.4

6.3

331

2484

I45.6

ICD-10 Finland

Pre-excitation syndrome

3.2

6.3

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

2.1

6.3

276

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

6.3

113

681

QDA10

NOMESCO Finland

Incision of skin of lower limb

2.5

6.3

155

N178, I420,

ICD-10 Finland

+∞

6.2

JN4BD

NOMESCO Finland

Extensive body CT

1.3

6.2

440

3445

I25.8

ICD-10 Finland

Other forms of chronic ischaemic heart disease

1.9

6.2

366

G04CA02

ATC

tamsulosin; oral

0.8

6.2

1202

13669

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.3

6.2

541

4352

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.9

6.2

409

SPAT1301

SPAT

No procedures

1.2

6.2

1249

10955

A69.2

ICD-10 Finland

Lyme disease

0.6

6.2

102

1676

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

2.1

6.1

265

K29.0

ICD-10 Finland

Acute haemorrhagic gastritis

2.7

6.1

121

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.3

6.1

522

4189

H40.0

ICD-10 Finland

Glaucoma suspect

0.7

6.1

156

2326

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.1

6.1

266

Q21.19

ICD-10 Finland

Atrial septal defect NOS

4.1

6.1

I31.1

ICD-10 Finland

Chronic constrictive pericarditis

12.5

6.1

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

2.7

6.1

116

A10AB06

ATC

insulin glulisine; parenteral

2.2

6.1

214

S01ED51

ATC

timolol, combinations; ophthalmic

0.7

6.0

169

2475

K76.1

ICD-10 Finland

Chronic passive congestion of liver

8.6

6.0

Q21.00

ICD-10 Finland

Multiple ventricular septal defect

8.6

6.0

2AX04, ,

NOMESCO Finland

10.0

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2312

8026

4.51

307.65

3.8

2.8

2.32

2.25

g/l

9.27

2220

7433

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2254

7459

4.69

307.65

3.8

2.8

23.27

22.64

1.42

2174

6961

(3022948) Iron [Moles/volume] in Serum or Plasma

2374

8501

4.42

307.65

3.8

2.8

13.60

12.60

umol/l

8.19

2293

7942

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3795

15708

6.92

307.65

9.6

3.2

2670.87

1604.77

ng/l

22.96

3661

13669

(3027456) Digoxin [Moles/volume] in Serum or Plasma

588

1026

6.36

307.65

3.3

3.2

0.79

0.82

nmol/l

0.58

469

811

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1587

4212

5.06

307.65

6.1

3.0

437.78

206.56

ng/l

31.43

1538

3860

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

536

1171

5.01

231.40

2.1

2.0

11.05

12.24

mg/l

2.19

497

1090

(3020779) Urea [Moles/volume] in Serum or Plasma

1270

5179

2.95

217.11

17.9

7.7

12.70

10.69

mmol/l

13.99

1217

4956

(3032080) INR in Blood by Coagulation assay

3471

23283

2.61

208.22

43.0

17.6

1.67

1.32

inr

153.62

3119

19678

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2249

12480

2.46

203.29

3.1

2.4

2.92

2.86

mg/l

0.56

2033

10731

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

683

2038

3.72

193.95

4.6

3.5

4.22

4.46

pmol/l

6.53

640

1810

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2955

18855

2.39

190.39

4.5

3.1

183.20

169.80

ug/l

0.69

2841

17431

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1693

8450

2.52

190.19

7.5

3.5

0.82

0.81

mmol/l

0.98

1617

7984

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

612

1907

3.52

161.48

2.1

1.9

31.84

39.08

u/l

10.28

409

1666

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1762

9760

2.25

148.69

6.9

4.2

732.14

568.94

ng/l

0.25

1655

8284

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

598

1943

3.36

147.15

6.4

3.0

0.36

0.33

iu/ml

0.93

368

1068

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1361

6902

2.34

140.49

8.9

6.7

1.11

1.04

mmol/l

14.58

1290

6481

(3000991) Gas panel - Venous blood

995

4748

2.37

115.50

18.5

9.5

—

(3026250) Tacrolimus [Mass/volume] in Blood

149

206

7.42

102.07

43.8

40.0

7.79

7.23

ug/l

2.60

138

189

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2616

18496

1.87

99.48

6.6

4.2

98.90

67.74

ng/l

0.35

2226

14221

(3042733) HLA Ab [Presence] in Serum

127

152

8.55

98.24

5.2

4.7

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1191

6484

2.10

98.07

15.1

8.1

4.96

5.08

kpa

3.17

1136

6247

(3019977) pH of Arterial blood

1188

6467

2.10

97.82

15.1

8.1

7.42

0.57

632

3576

(3027801) Oxygen [Partial pressure] in Arterial blood

1190

6483

2.10

97.77

15.1

8.1

11.13

12.10

kpa

12.44

1132

6246

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1057

5536

2.15

96.07

6.3

4.0

5.86

5.81

kpa

0.90

1024

5395

(3003396) Base excess in Arterial blood by calculation

1177

6429

2.09

95.77

15.2

8.0

0.58

0.86

mmol/l

1.29

959

5286

(3002032) Base excess in Venous blood by calculation

1031

5402

2.15

93.32

6.4

4.0

1.59

1.73

mmol/l

0.55

895

4679

(3023368) Bacteria identified in Blood by Culture

2164

14670

1.84

91.67

6.1

4.7

—

(3012544) pH of Venous blood

1058

5633

2.11

91.66

6.5

4.0

7.37

7.38

2.08

650

3317

(3014111) Lactate [Moles/volume] in Serum or Plasma

946

4920

2.14

86.62

17.1

8.1

1.49

1.38

mmol/l

1.87

916

4823

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

908

4649

2.17

86.55

3.4

2.4

19.02

7.96

ug/l

6.76

841

4109

(3016502) Oxygen saturation in Arterial blood

1074

5870

2.06

86.12

16.2

8.3

94.86

95.40

1.52

1043

5671

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

691

3207

2.34

83.37

7.0

4.0

23.87

24.07

mmol/l

0.83

680

3166

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

706

3363

2.28

79.93

19.8

10.1

24.04

24.16

mmol/l

0.40

685

3299

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3135

24344

1.77

78.96

10.9

7.1

15.01

12.68

umol/l

14.67

3042

23326

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

391

1428

2.89

77.10

5.8

2.6

3.75

3.57

g/l

1.36

376

1367

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3045

23542

1.75

76.87

13.8

8.1

1.19

1.21

mmol/l

28.12

2670

20421

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2790

21171

1.72

74.09

13.4

7.3

1.19

1.20

mmol/l

19.57

2652

19638

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

583

2648

2.36

73.42

1.8

1.7

1.53

1.54

g/l

0.07

512

2289

(3042936) Bacteria identified in Isolate by Culture

1187

7078

1.89

72.22

2.8

2.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1398

8775

1.82

72.20

2.2

2.0

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

712

3549

2.17

71.60

18.9

8.8

24.31

24.75

mmol/l

2.20

707

3529

(3002173) Hemoglobin [Mass/volume] in Arterial blood

966

5422

1.97

70.27

17.6

8.9

123.59

121.69

g/l

1.85

952

5298

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1099

6456

1.90

69.70

9.9

4.5

261.35

242.85

u/l

2.98

1053

6122

(3018418) pH of Serum or Plasma

1998

14021

1.71

69.21

6.0

4.5

7.39

7.40

1.25

1542

10151

(3013826) Glucose [Moles/volume] in Serum or Plasma

3387

27481

1.72

66.87

11.1

5.6

7.04

6.88

mmol/l

3.58

3295

26359

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

456

1944

2.48

65.81

4.6

2.3

897.58

637.38

ug/l

0.33

445

1859

(3024932) HLA-DR beta [Type]

136

7.25

65.58

1.0

1.1

—

(3024471) HLA-A [Type]

138

7.15

64.72

1.0

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1462

9551

1.75

64.58

5.8

1.8

1.56

1.43

mg/l

0.59

1191

7538

(3001604) Monocytes [#/volume] in Blood

2900

22770

1.65

62.91

8.9

6.4

0.65

0.63

e9/l

4.87

2534

19368

(3024561) Albumin [Mass/volume] in Serum or Plasma

2737

21211

1.64

62.25

6.3

5.6

34.06

35.08

g/l

16.37

2615

19912

(3036489) Thrombin time

412

1718

2.52

62.24

5.9

2.2

22.23

21.34

1.02

398

1562

(3022493) Free Hemoglobin [Mass/volume] in Plasma

118

214

5.62

62.03

38.7

3.2

77.30

67.70

mg/l

0.41

105

149

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1033

6148

1.86

62.01

2.1

1.9

—

(3006315) Basophils [#/volume] in Blood

2903

22847

1.65

61.96

8.9

6.4

0.04

e9/l

0.90

2533

19451

(42870588) Differential panel, method unspecified - Blood

2154

15755

1.65

61.45

9.1

6.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1084

6592

1.82

60.52

2.0

1.9

—

(3013115) Eosinophils [#/volume] in Blood

2961

23494

1.64

60.50

9.5

6.7

0.19

0.20

e9/l

4.28

2608

20290

(3019198) Lymphocytes [#/volume] in Blood

2929

23231

1.63

59.45

9.0

6.5

1.76

1.89

e9/l

1.62

2589

20253

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1255

8030

1.75

58.68

6.1

2.2

32.26

29.93

21.25

1228

7820

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

172

449

3.93

57.95

1.4

1.2

88.28

97.81

3.52

172

420

(3021589) Normoblasts [#/volume] in Blood

2524

19432

1.61

56.82

17.0

12.7

0.00

e9/l

0.53

2103

15834

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

166

6.06

56.47

2.8

2.0

194.94

168.52

2.02

160

(3019069) Monocytes/Leukocytes in Blood

2695

21126

1.60

55.84

9.3

6.8

9.30

9.19

1.14

2598

19767

(3006504) Eosinophils/Leukocytes in Blood

2689

21070

1.60

55.80

9.2

6.7

2.67

2.89

5.90

2590

19711

(3002030) Lymphocytes/Leukocytes in Blood

2727

21464

1.60

55.32

9.2

6.8

23.49

26.32

34.02

2640

20309

(3022096) Basophils/Leukocytes in Blood

2684

21053

1.60

55.19

9.3

6.8

0.63

0.66

3.03

2583

19700

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

236

785

3.11

54.68

1.4

1.3

279.54

264.79

u/ml

0.35

170

479

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

9.95

54.25

1.5

1.3

4.15

346304.15

nmol/l

0.49

(3023183) Ammonium ion [Moles/volume] in Plasma

317

1248

2.64

53.75

2.5

2.7

30.57

34.72

umol/l

2.12

288

1113

(3018010) Neutrophils/Leukocytes in Blood

2674

21060

1.58

53.21

9.1

6.6

61.01

58.24

27.90

2599

20091

(3024354) Oxygen [Partial pressure] in Venous blood

799

4581

1.89

53.13

5.4

3.4

4.49

4.54

kpa

0.26

766

4454

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

199

609

3.36

52.89

1.5

1.2

2.90

4.73

u/ml

1.38

111

295

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

201

620

3.34

52.76

1.5

1.2

2.74

3.13

u/ml

0.15

215

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

234

796

3.04

52.14

1.7

1.5

146.44

152.50

au/ml

0.29

242

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

154

404

3.90

51.53

2.3

2.4

21.80

31.22

iu/ml

0.52

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

252

901

2.89

51.36

1.6

1.5

—

(4195642) Thrombophilia screening test

185

552

3.44

51.17

1.5

1.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1807

13104

1.59

50.48

3.8

3.1

407.65

360.99

umol/l

45.15

1614

11506

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

106

212

5.09

50.03

1.3

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

241

856

2.91

49.71

1.4

1.3

—

98.15

—

(3020630) Protein [Mass/volume] in Serum or Plasma

798

4673

1.84

49.33

2.1

2.7

64.18

66.14

g/l

9.87

751

4275

(3033658) Prothrombin time (PT) actual/Normal

1669

11934

1.60

49.17

7.2

4.6

69.66

84.84

78.96

1638

11714

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

187

577

3.33

49.05

1.4

1.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

103

206

5.08

48.62

22.1

28.1

114.02

116.89

ug/l

0.14

167

(3014148) Varicella zoster virus Ab [Titer] in Serum

154

422

3.73

48.42

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

227

793

2.95

48.24

9.3

6.6

11.39

12.05

mg/l

1.28

209

733

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1981

14858

1.55

46.78

3.7

3.4

43.33

37.86

u/l

0.83

1879

13999

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

804

4814

1.80

45.92

2.2

2.3

0.19

0.20

g/l

3.18

744

4475

(3013650) Neutrophils [#/volume] in Blood by Automated count

3056

25345

1.53

44.26

11.9

10.0

4.53

4.31

e9/l

5.20

2691

21837

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

8.14

43.52

1.6

1.3

82.27

77.45

0.40

(3045788) Cell count panel - Pleural fluid

183

600

3.13

43.43

1.5

1.4

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

588

3268

1.91

42.39

23.1

10.5

16.18

16.02

0.60

571

3156

(3023199) Leukocytes [#/volume] in Pleural fluid

209

750

2.86

42.28

1.5

6903.56

3040.73

e6/l

0.36

144

523

(3044889) 12 lead EKG panel

3575

30858

1.56

41.67

8.6

4.5

0.57

5340.58

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

192

667

2.95

41.20

1.4

31483.76

66747.77

e6/l

1.47

120

383

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

862

5425

1.71

40.91

2.8

3.0

10.56

9.42

umol/l

1.05

787

4866

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

623

3569

1.85

40.78

1.7

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

266

1123

2.45

38.84

1.4

1.3

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

7.68

38.62

1.5

1.3

79.83

77.00

0.19

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

257

1072

2.47

38.52

10.0

5.8

1234.30

2746.23

iu/ml

0.43

164

(3003434) Protein [Mass/volume] in Pleural fluid

224

878

2.62

38.22

1.5

25.99

32.14

g/l

10.23

185

792

(3027945) Reticulocytes/Erythrocytes in Blood

977

6504

1.62

36.94

2.8

2.6

1.90

1.77

3.31

894

5779

(3034426) Prothrombin time (PT)

129

5.41

35.16

1.7

1.3

30.34

28.46

1.42

129

(40758558) Short blood count panel - Blood

1746

13360

1.47

34.45

9.6

6.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

265

1187

2.30

33.82

1.5

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

319

1543

2.14

33.72

1.8

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

502

2851

1.85

33.47

1.6

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

541

3144

1.81

33.47

4.9

3.8

2.02

1.72

mmol/l

0.93

382

2297

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3825

34071

1.53

33.45

13.1

8.9

83.32

80.99

u/l

1.87

3704

32421

(3052851) Hemolysis interference index of Serum or Plasma

280

1296

2.23

33.04

5.9

3.5

3.58

1.74

index

2.63

171

684

(3024928) Oxygen saturation in Venous blood

292

1383

2.18

32.55

6.4

3.0

61.87

61.16

0.22

277

1338

(3028626) Oxygen [Partial pressure] in Capillary blood

299

1430

2.16

32.52

4.8

3.5

8.08

8.00

kpa

0.38

291

1400

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

232

1006

2.37

31.90

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

232

1006

2.37

31.90

1.4

1.3

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1912

15065

1.44

31.55

2.9

2.3

258.55

234.96

u/l

0.39

1832

14249

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

608

3715

1.72

31.53

5.2

3.9

5.10

5.14

kpa

0.39

582

3560

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

581

3508

1.74

31.44

5.6

4.4

132.17

99.19

ng/l

7.83

527

3034

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

7.07

31.33

1.3

1.2

44.57

90.79

ng/l

0.56

(3017143) Hepatitis C virus Ab [Presence] in Serum

679

4283

1.68

31.28

1.8

1.6

—

(4268621) Lupus anticoagulant assay

132

435

3.09

31.10

3.1

2.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

172

4.47

31.01

2.1

5818.98

16780.73

e6/l

0.49

(3030467) Casts [#/volume] in Urine by Automated count

1769

13800

1.44

30.55

3.8

3.6

0.72

0.44

e6/l

2.48

1361

10348

(40768806) Pleura Pathology biopsy report

170

653

2.66

30.22

1.4

1.6

—

(3009343) pH of Capillary blood

586

3607

1.71

29.48

5.1

4.0

7.41

1.08

518

2993

(3002582) Erythrocytes [#/volume] in Urine

2003

16050

1.41

29.48

3.8

3.7

90.22

92.36

e6/l

0.03

1595

12526

(1616796) Gas panel - Central venous blood

259

1222

2.18

29.13

4.3

4.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

536

3231

1.74

29.07

1.9

1.8

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

204

4.02

28.77

2.2

2.3

581.25

4408.13

e6/l

0.54

149

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

289

1433

2.08

28.58

1.3

13.54

13.61

iu/ml

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

737

4867

1.60

28.07

1.8

1.6

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

390

2166

1.87

27.77

1.3

1.6

11.00

18.95

iu/ml

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

343

1831

1.94

27.55

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

679

4430

1.62

27.12

2.5

2.6

38.97

50.94

u/l

0.55

576

3789

(3006184) Hemoglobin [Mass/volume] in Capillary blood

262

1285

2.10

26.67

2.5

2.3

131.42

129.45

g/l

0.53

186

993

(46235355) HIV 1 and 2 tests - Meaningful Use set

830

5700

1.55

26.54

2.0

1.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

252

1225

2.11

26.26

1.5

1.6

—

(3018095) Leukocytes [#/volume] in Urine

2131

17495

1.38

26.13

4.5

4.3

85.76

98.13

e6/l

0.31

1610

12928

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

108

354

3.10

25.74

1.1

1.2

96.00

110.00

titre

0.17

(3021901) Oxygen saturation in Capillary blood

247

1201

2.11

25.72

3.7

3.1

89.24

89.05

0.15

242

1171

(3008152) Bicarbonate [Moles/volume] in Arterial blood

548

3431

1.67

25.70

9.7

7.1

24.04

24.43

mmol/l

1.36

525

3289

(3004119) Hemoglobin [Mass/volume] in Venous blood

544

3407

1.67

25.47

5.7

3.4

128.94

129.07

g/l

0.04

525

3312

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

312

1668

1.93

24.93

1.8

2.3

0.01

0.03

g/l

1.91

282

1501

(1761868) Lipid panel - Serum or Plasma

1145

14989

0.69

24.93

3.6

3.5

—

(3012501) Base excess in Blood by calculation

226

1076

2.15

24.85

4.6

4.9

2.44

2.55

mmol/l

0.22

139

729

(3027273) Bicarbonate [Moles/volume] in Venous blood

420

2482

1.76

24.29

4.6

3.7

24.70

25.13

mmol/l

1.51

402

2396

(3037522) Nuclear Ab [Titer] in Serum

804

5581

1.53

24.28

1.3

401.46

457.47

titre

0.41

137

1145

(3036782) Glucose [Moles/volume] in Pleural fluid

151

611

2.52

24.19

1.3

1.4

6.87

6.28

mmol/l

1.43

142

571

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

294

1570

1.93

23.56

1.2

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

168

3575

0.45

23.34

1.8

2.1

3.79

3.63

ratio

0.84

143

2898

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

284

1507

1.94

23.19

1.8

2.4

0.00

g/l

-0.00

266

1415

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

299

1617

1.90

23.07

1.8

2.3

0.00

g/l

0.50

266

1418

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

291

1566

1.91

22.79

4.5

3.5

1.99

1.66

mg/l

6.42

272

1425

(3023520) Reticulocytes [#/volume] in Blood

741

5134

1.52

22.44

2.9

2.7

72.86

68.34

e9/l

2.11

527

3833

(3000850) Epithelial cells [#/volume] in Urine

1436

11265

1.39

22.33

3.0

2.9

4.26

3.94

e6/l

0.61

1340

10306

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

342

1955

1.80

22.11

2.4

3.5

45.05

58.64

mg/l

0.78

286

1664

(3034860) Kappa light chains.free [Mass/volume] in Serum

342

1957

1.80

22.04

2.4

3.5

52.32

55.36

mg/l

0.29

287

1666

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

366

2147

1.76

21.67

1.9

2.4

3.10

2.91

g/l

3.10

341

1954

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

314

1768

1.83

21.33

2.3

3.4

1.72

2.92

ratio

2.02

168

1043

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3383

30345

1.36

21.32

5.1

3.9

15.54

14.91

pmol/l

31.15

3159

27548

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

402

2435

1.71

21.22

2.2

1.9

5.41

2.43

ug/l

0.40

365

2155

(3051611) Lipemic interference index of Serum or Plasma

115

436

2.68

21.07

8.3

3.4

13.63

12.04

index

0.98

249

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1679

20253

0.74

20.80

3.9

4.7

22.98

22.10

1.45

788

10363

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

341

1988

1.77

20.62

1.8

2.4

10.15

10.25

g/l

0.16

311

1777

(3044007) Cell count panel - Peritoneal fluid

174

3.71

20.51

2.5

1.9

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

189

906

2.13

20.45

1.7

1.9

156.91

10.61

iu/l

0.69

337

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

180

849

2.16

20.30

4.2

2.9

4820.50

1962.95

u/ml

0.28

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1435

11397

1.36

20.27

3.3

2.6

—

(3018405) Lactate [Moles/volume] in Arterial blood

314

1802

1.79

20.03

5.5

4.1

1.45

1.42

mmol/l

0.20

308

1776

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

380

2303

1.70

20.00

1.9

2.4

3.73

3.76

g/l

0.16

354

2109

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

429

2686

1.65

19.96

1.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

337

1977

1.76

19.93

1.9

2.5

0.32

1.02

g/l

6.30

298

1695

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

380

2307

1.70

19.87

1.9

2.4

4.05

4.17

g/l

2.61

354

2115

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

380

2307

1.70

19.87

1.9

2.4

7.28

7.35

g/l

0.30

354

2111

(3020891) Body temperature

405

2514

1.66

19.47

5.9

4.7

36.92

36.91

°c

0.07

399

2482

(3002331) Protein [Mass/volume] in Peritoneal fluid

131

4.08

19.40

1.6

1.3

31.22

26.15

g/l

1.70

104

(3044640) Blood type and Crossmatch panel - Blood

1795

14833

1.33

19.20

3.4

2.7

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2179

25168

0.76

19.07

4.5

5.8

2.65

3.13

ug/l

0.87

1944

22801

(21494755) Public health laboratory ask at order entry panel

136

2898

0.45

18.85

1.3

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

253

1387

1.87

18.72

1.6

1.7

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

218

1138

1.96

18.70

1.6

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

168

3.60

18.45

1.4

1.6

18.66

13.07

g/l

5.60

131

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

112

2515

0.43

17.81

1.5

1.8

3.38

3.44

mmol/l

0.20

1819

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

247

1366

1.85

17.78

1.6

1.7

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

139

628

2.25

17.48

1.3

521.93

367.95

u/l

0.19

132

598

(3035880) pH of Pleural fluid

333

2.73

17.35

1.2

1.3

7.40

0.01

234

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

693

4976

1.46

17.26

4.7

3.8

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

145

673

2.19

17.08

1.5

1.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

322

2.73

16.78

1.3

1.2

86.56

84.28

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

199

1046

1.94

16.75

1.3

1.2

—

(3026782) Osmolality of Urine

1206

9591

1.34

16.22

3.1

3.2

512.63

551.37

mosm/kgh2o

9.75

1088

8458

(3024891) Influenza virus A+B Ag [Presence] in Specimen

194

1024

1.93

16.14

1.2

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

118

3.93

16.06

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

5.99

16.03

2.2

2.6

0.81

0.63

ug/l

0.99

(42529406) Shigella sp [Presence] in Stool by Culture

197

1052

1.91

15.83

1.3

1.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1758

14772

1.29

15.79

3.2

2.8

60.07

67.55

u/l

0.68

1664

13777

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

246

1410

1.78

15.77

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

324

2015

1.65

15.44

2.6

2.7

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

194

1042

1.90

15.33

1.3

1.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

110

480

2.32

15.06

1.2

1.3

12.53

13.19

u/l

0.05

443

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1094

8694

1.33

14.56

3.4

3.3

1.32

1.01

e6/l

1.26

581

4803

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

222

1275

1.78

14.16

1.5

1.20

1.19

g/l

0.28

207

1214

(3022313) Gas panel - Capillary blood

384

2543

1.55

14.07

5.6

4.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1019

8051

1.33

14.05

3.5

2.17

1.41

e6/l

1.82

504

4149

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

215

1235

1.77

13.71

1.4

1.5

0.25

0.24

g/l

0.40

198

1176

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

405

2735

1.52

13.57

5.0

4.3

45.73

47.24

0.61

400

2692

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

158

3.25

13.51

6.2

7.0

5.87

5.95

kpa

0.32

139

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

189

1051

1.83

13.43

1.2

1.3

17.78

37.80

u/l

4.67

172

907

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

261

2.71

13.39

1.2

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

261

2.71

13.39

1.2

1.6

—

(3026008) Bacteria identified in Urine by Culture

1526

12825

1.27

13.07

3.1

3.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

138

699

2.00

13.00

1.5

1.6

—

(3028026) IgM [Mass/volume] in Serum or Plasma

406

2773

1.51

12.88

1.7

2.0

1.16

1.34

g/l

0.91

381

2535

(3038071) Oxygen [Partial pressure] in Mixed venous blood

138

3.36

12.84

5.8

7.1

5.31

5.40

kpa

0.10

138

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

162

873

1.88

12.73

1.4

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1537

17958

0.79

12.49

1.9

2.0

1.49

1.37

mmol/l

5.35

1291

14974

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

531

3843

1.43

12.49

3.3

2.8

52.58

63.83

ml/min/173m2

10.93

275

1649

(44816559) Phosphatidylethanol [Mass/volume] in Blood

294

1888

1.59

12.32

1.7

0.37

0.33

mg/l

0.51

143

958

(3012516) Albumin [Mass/volume] in Urine

1923

16691

1.25

12.30

3.7

3.6

67.06

51.76

mg/l

1.74

1427

11286

(3020682) Albumin/Creatinine [Ratio] in Urine

1958

17039

1.25

12.20

4.5

4.3

12.40

9.11

mg/mmol

1.95

1408

11155

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

251

2.65

12.18

1.2

1.3

42.55

23.31

u/l

2.85

206

(3031040) Bacteria [#/volume] in Urine by Automated count

3094

28317

1.24

12.04

5.1

4.9

1150.62

1330.75

e6/l

0.07

457

(3019309) Folate [Moles/volume] in Red Blood Cells

1046

8460

1.30

11.95

1.8

1232.96

1151.29

nmol/l

1.89

830

6376

(3007566) Smooth muscle Ab [Titer] in Serum

209

1244

1.71

11.80

1.2

69.47

142.54

titre

2.02

118

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

211

1260

1.70

11.77

1.5

1.6

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1084

0.31

11.77

1.0

1.2

0.66

ratio

—

156

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

169

947

1.81

11.76

1.6

1.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1259

14980

0.79

11.75

2.9

3.3

0.79

ug/l

0.05

896

10153

(3009508) Creatinine [Moles/volume] in Urine

1972

17227

1.24

11.72

3.7

3.6

7.23

7.94

mmol/l

12.23

1694

14478

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

199

1172

1.73

11.68

1.4

1.5

—

(3005719) IgG [Mass/volume] in Serum or Plasma

489

3533

1.43

11.59

2.8

10.59

10.61

g/l

0.03

462

3251

(3025941) Bacteria identified in Stool by Culture

310

2052

1.54

11.39

1.3

—

(44790048) Parainfluenza type 2 nucleic acid detection

128

668

1.94

11.12

1.6

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

128

668

1.94

11.12

1.6

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

128

668

1.94

11.12

1.6

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

128

668

1.94

11.12

1.6

1.5

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

106

3.51

11.12

1.1

1.2

58.46

82.97

3.32

(3004716) Salmonella sp identified in Stool by Organism specific culture

238

1491

1.63

11.06

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

174

1009

1.75

10.81

1.4

1.5

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

261

2.51

10.79

1.2

130.70

97.34

u/l

1.53

216

(3017446) Testosterone [Moles/volume] in Serum or Plasma

424

5798

0.71

10.42

2.5

2.3

12.41

13.46

nmol/l

1.59

373

5200

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

106

3.41

10.39

1.1

1.4

48.04

80.85

4.60

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2331

20894

1.22

10.35

3.6

3.0

—

estimate

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1610

13970

1.23

9.70

1.9

1.7

18.72

19.48

nmol/l

1.33

1435

11857

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1167

0.40

9.66

1.0

1.2

1.39

1.47

g/l

1.51

1167

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

500

3751

1.37

9.47

4.9

4.4

1.21

1.22

mmol/l

5.04

459

3278

(3047181) Lactate [Moles/volume] in Blood

245

1610

1.55

9.34

8.7

6.1

1.49

1.35

mmol/l

0.84

218

1427

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

8.66

9.27

2.9

6.2

110.68

104.09

g/l

0.75

(3015377) Calcium [Moles/volume] in Serum or Plasma

1751

15402

1.21

9.04

3.8

3.7

2.33

2.35

mmol/l

4.18

1583

13965

(43055442) Apixaban [Mass/volume] in Serum or Plasma

3.31

8.87

1.8

1.5

117.04

127.46

ug/l

0.17

(3039443) Prostate specific Ag panel - Serum or Plasma

1253

0.46

8.44

1.7

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

386

2.06

8.36

1.1

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

159

969

1.66

8.32

1.2

76.00

321.82

titre

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

525

4051

1.33

8.25

2.4

396.21

376.07

nmol/l

1.35

497

3765

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

181

2.56

8.06

1.9

2.7

0.62

0.61

mmol/l

0.37

181

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

104

567

1.85

8.03

3.5

3.7

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

283

1979

1.46

8.03

6.1

4.2

24.72

24.71

mmol/l

0.02

265

1810

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

343

2493

1.40

7.87

7.2

5.2

1.67

1.62

0.48

326

2359

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

3.78

7.78

1.6

1.4

63.15

75.15

0.72

(3035947) Staphylolysin Ab [Units/volume] in Serum

252

2.28

7.76

1.2

1.1

3.50

3.70

iu/ml

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

454

1.93

7.69

1.1

1.2

89.09

66.23

u/l

0.31

401

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

183

2.47

7.39

1.1

253.31

202.83

iu/ml

0.27

183

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

280

2.16

7.20

2.2

2.0

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

101

567

1.80

7.14

1.3

1.6

67.69

61.52

0.83

365

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

280

1999

1.42

7.13

2.3

2.0

—

(3000475) Leukocytes [#/volume] in Synovial fluid

191

1267

1.53

7.06

1.7

1.6

11739.33

16317.29

e6/l

1.28

135

886

(3006576) Bicarbonate [Moles/volume] in Blood

189

2.39

6.92

6.0

7.7

25.71

24.70

mmol/l

0.94

170

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

430

1.90

6.85

1.4

1.6

—

(4094501) Cardiovascular stress test using bicycle ergometer

1394

0.54

6.83

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

259

1841

1.43

6.77

2.1

1.8

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

136

845

1.63

6.68

1.4

1.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

311

2294

1.38

6.57

7.6

5.5

0.84

0.86

0.42

292

2167

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

157

1017

1.56

6.49

1.4

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3912

37512

1.20

6.31

6.2

4.9

2.14

1.97

mu/l

4.99

3689

34278

(3042631) Mycobacterium sp identified in Specimen

123

760

1.63

6.20

2.2

2.8

—

(3003181) Sodium [Moles/volume] in Urine

142

910

1.58

6.17

1.6

1.4

58.06

61.54

mmol/l

0.48

107

731

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

116

714

1.64

5.96

1.2

1.3

—

(3017569) Oxygen content in Arterial blood

337

1.94

5.95

2.1

2.2

16.54

16.13

0.42

337

(3001964) Herpes simplex virus Ag [Presence] in Specimen

112

2.69

5.91

1.2

1.6

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

176

1198

1.49

5.82

4.8

1.7

8.51

5.06

mg/l

1.73

160

899

(4281824) Cell count and differential, peritoneal fluid

341

1.92

5.76

1.5

1.2

—

(4035726) Immunohistochemistry procedure

499

4014

1.27

5.73

2.1

1.4

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

200

2.21

5.71

1.3

1.5

3.25

2.34

0.27

170

(3005532) Lymphocytes/Leukocytes in Pleural fluid

241

2.09

5.61

1.3

1.5

57.43

66.03

0.78

196

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

130

838

1.57

5.55

1.1

1.2

—

1.06

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

112

698

1.62

5.50

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

105

645

1.64

5.47

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

336

1.89

5.34

2.0

8.62

8.02

mmol/l

0.60

336

(3037756) Immunofixation for Serum or Plasma

176

1220

1.46

5.34

1.4

1.7

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1267

0.58

5.29

1.4

1.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

608

5055

1.23

5.22

1.8

1.68

1.56

2.73

508

4338

(3011397) Hemoglobin [Presence] in Urine by Test strip

1202

10644

1.17

5.16

4.0

3.7

0.14

0.13

—

127

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

3334

31745

1.15

5.10

5.7

4.5

15.29

12.76

mm/h

14.36

3155

29622

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

551

1.66

5.04

1.7

1.8

—

(3008536) Aspergillus sp Ab [Presence] in Serum

116

2.51

5.03

1.7

2.0

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

521

1.68

5.03

1.7

1.9

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2251

20885

1.14

5.02

2.3

2.2

92.66

93.36

pmol/l

0.29

1315

11657

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

434

3494

1.27

4.97

1.5

1.4

—

(3004451) EKG impression Narrative

316

1.88

4.96

1.2

1.3

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

2.74

4.93

1.3

1.2

86.83

373.95

u/l

0.38

(3026051) Granulocytes/Leukocytes in Pleural fluid

142

2.33

4.90

1.5

1.3

32.23

23.76

0.71

114

(3002619) Bacteria identified in Specimen by Culture

2.67

4.90

1.4

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

262

1975

1.34

4.90

1.4

1.7

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4237

41151

1.20

4.83

32.7

18.9

26.13

27.55

mg/l

2.29

3896

34697

(3010838) Calcium [Moles/time] in 24 hour Urine

108

691

1.58

4.81

2.0

1.9

4.29

4.72

mmol/24h

0.72

602

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

3511

33607

1.15

4.81

40.6

23.1

14.35

13.77

82.33

3483

33166

(3010813) Leukocytes [#/volume] in Blood

4340

44407

0.83

4.76

48.8

28.2

7.25

6.88

e9/l

10.94

4259

43309

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

357

1.80

4.75

1.0

1.1

306.63

282.96

mg/l

1.43

325

(3000963) Hemoglobin [Mass/volume] in Blood

4340

44406

0.83

4.75

49.1

28.4

133.71

136.34

g/l

20.31

4299

43910

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

365

1.79

4.73

1.3

1.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

616

1.60

4.71

8.3

18.4

7.18

7.35

mmol/l

0.22

525

(3011544) Albumin [Mass/volume] in Pleural fluid

2.95

4.70

1.0

1.1

13.29

17.21

g/l

1.75

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

315

1.85

4.70

1.3

1.6

—

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

4340

44400

0.83

4.69

51.7

28.8

40.38

40.88

1.90

4294

43874

(3026361) Erythrocytes [#/volume] in Blood

4340

44400

0.83

4.69

48.7

28.1

4.42

4.50

e12/l

15.93

4263

43309

(3035941) MCH [Entitic mass]

4340

44397

0.83

4.67

48.5

28.0

30.56

30.54

0.31

4294

43894

(3024731) MCV [Entitic mean volume] in Red Blood Cells

4340

44397

0.83

4.67

48.5

28.1

92.56

91.59

33.69

4295

43892

(3007461) Platelets [#/volume] in Blood

4339

44387

0.83

4.66

48.7

28.2

223.99

238.48

e9/l

40.88

4271

43457

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

550

1.63

4.59

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

125

840

1.50

4.49

1.2

1.3

—

12.42

—

(3028433) Virus identified in Specimen by Culture

155

2.20

4.45

1.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

111

729

1.53

4.44

1.9

2.4

1.34

1.31

g/24h

0.03

444

(3007164) IgA [Mass/volume] in Serum or Plasma

876

7650

1.18

4.41

1.5

2.72

2.69

g/l

0.17

588

4698

(3024980) IgG subclass 4 [Mass/volume] in Serum

115

764

1.52

4.37

1.6

0.80

0.90

g/l

0.39

604

(3003329) Lymphocytes/Leukocytes in Synovial fluid

435

1.69

4.35

1.3

1.6

23.23

25.69

0.29

269

(40768800) Prostate Pathology biopsy report

116

1702

0.67

4.28

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

340

1.77

4.27

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

2.84

4.22

1.0

1.2

14.34

20.40

u/l

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

108

2.41

4.21

1.3

1.5

12.78

7.74

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

327

1.78

4.20

1.3

1.6

—

(3000494) Fungus identified in Specimen by Culture

651

5566

1.20

4.19

1.8

1.5

—

(3023420) DNA double strand Ab [Units/volume] in Serum

218

1641

1.34

4.16

1.5

1.6

7.65

6.39

iu/ml

0.22

379

(4062490) Immunoglobulin typing, IgG

456

1.65

4.16

1.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

5.25

4.14

2.4

2.9

—

(3023419) Bacteria identified in Sputum by Culture

107

713

1.51

4.04

1.8

2.7

—

(3035715) Granulocytes [#/volume] in Blood

119

811

1.48

4.03

2.6

3.5

4.65

4.34

e9/l

0.60

119

811

(3027135) IgG subclass 1 [Mass/volume] in Serum

463

1.63

3.94

1.4

1.3

7.13

6.83

g/l

0.30

337

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.26

3.90

1.1

1.4

—

(3045716) Anion gap in Serum or Plasma by calculation

607

1.54

3.87

2.8

3.4

10.83

10.74

mmol/l

0.09

599

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

458

1.62

3.86

1.6

—

(37208534) Antinuclear antibody arbitrary concentration in serum

133

2.19

3.79

1.0

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

463

1.61

3.71

1.4

1.3

0.48

0.41

g/l

0.77

335

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

139

994

1.41

3.68

1.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

109

2.30

3.68

7.8

7.3

10.67

10.30

0.32

109

(3028192) IgG subclass 2 [Mass/volume] in Serum

464

1.60

3.68

1.4

1.3

3.08

2.99

g/l

0.21

337

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

109

746

1.47

3.65

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

131

930

1.42

3.62

1.2

1.1

1.90

3.33

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

562

1.54

3.59

1.3

1.86

1.49

nmol/l

1.67

497

(3014891) Appearance of Pleural fluid

2.51

3.54

1.7

1.5

—

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

3.05

3.52

2.9

1.7

69.00

60.28

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

206

1.90

3.52

1.3

1.7

79.78

94.30

umol/l

0.37

112

(3018572) Chloride [Moles/volume] in Blood

153

1122

1.38

3.51

11.6

7.1

104.47

105.17

mmol/l

0.78

139

1005

(3039000) Anion gap in Blood by calculation

153

1122

1.38

3.51

11.6

7.1

12.27

11.42

mmol/l

2.05

139

1005

(3037121) Protein [Mass/volume] in Urine

218

1686

1.31

3.50

2.9

3.5

313.23

428.08

mg/l

1.04

118

833

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

111

773

1.45

3.42

1.3

157.71

200.81

miu/ml

0.66

277

(1002224) Polysomnography panel

138

1881

0.73

3.42

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

433

0.44

3.41

1.2

1.4

156.78

188.46

pmol/l

0.43

433

(21494890) Protein electrophoresis panel - 24 hour Urine

579

1.51

3.36

1.4

2.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

328

1.68

3.35

2.0

2.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

154

2.02

3.34

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

114

2.20

3.34

1.0

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

277

1.74

3.29

3.1

4.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

277

1.74

3.29

2.3

2.0

—

(40761536) Microorganisms panel - Urine sediment

412

3458

1.21

3.27

4.1

4.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

479

1.55

3.26

1.5

1.3

131673.27

133225.75

e6/l

0.01

322

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.03

3.24

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

504

1.54

3.23

3.1

3.0

—

(3035933) Granulocytes/Leukocytes in Blood

133

969

1.38

3.20

2.9

3.5

61.66

58.62

1.86

133

969

(3000919) Neutrophils/Leukocytes in Pleural fluid

179

1.91

3.13

1.4

32.19

21.54

0.93

164

(3047007) Chlamydophila sp Ab [Presence] in Serum

476

1.54

3.13

1.2

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

105

2.20

3.08

1.3

1.2

0.81

1.79

mmol/l

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1037

9396

1.13

3.06

5.7

5.1

—

(3017181) Myelocytes/Leukocytes in Blood

511

4401

1.18

3.06

4.5

0.79

0.99

1.74

199

1481

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

103

729

1.42

2.96

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

165

1265

1.31

2.89

1.2

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

462

1.52

2.87

1.6

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

462

1.52

2.87

1.6

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

462

1.52

2.87

1.6

1.8

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

113

1539

0.73

2.84

1.6

1.9

219.23

207.88

pmol/l

0.43

107

1451

(44786800) Granulocytes/Leukocytes in Body fluid

2.34

2.81

1.1

1.4

14.45

26.36

0.69

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.34

2.80

1.4

1.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

187

1.82

2.78

1.1

1.5

—

(3023383) Lactate [Moles/volume] in Pleural fluid

195

1.80

2.75

1.3

1.4

2.64

3.32

mmol/l

0.97

178

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

478

5501

0.86

2.71

5.4

5.2

31.75

32.08

0.28

374

3640

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.24

2.70

1.0

1.1

1150.00

878.95

titre

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

226

1.73

2.69

1.5

1.6

—

(3002179) Metamyelocytes/Leukocytes in Blood

484

4198

1.17

2.68

4.5

4.3

0.66

0.73

0.23

188

1411

(3041918) Cholesterol [Moles/volume] in Pleural fluid

126

1.99

2.65

1.3

1.2

1.48

1.55

mmol/l

0.14

(3000060) B lymphocytes [#/volume] in Blood

106

2.08

2.62

2.4

2.2

0.11

0.46

e9/l

0.74

(3049233) Organic acids panel - Urine

7.15

2.55

1.2

1.0

—

(3021440) Promyelocytes/Leukocytes in Blood

481

4188

1.16

2.54

4.6

4.5

0.08

0.12

0.87

169

1278

(3020191) Ethanol [Moles/volume] in Serum or Plasma

403

1.52

2.53

1.4

1.3

1.22

1.23

promille

0.00

322

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

316

1.59

2.51

2.5

2.4

0.61

0.59

e9/l

0.12

301

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.27

2.50

1.3

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

270

1.64

2.49

1.8

2.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

270

1.64

2.49

1.8

2.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

270

1.64

2.49

1.8

2.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

270

1.64

2.49

1.8

2.1

—

(3024263) Appearance of Synovial fluid

263

1.64

2.47

1.4

1.6

—

(3011412) CD3 cells [#/volume] in Blood

438

1.49

2.46

2.5

2.4

946.72

1114.65

e6/l

1.08

387

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4267

43392

0.88

2.38

19.1

13.1

28.83

27.72

u/l

1.31

4177

42094

(3025549) Creatine [Moles/time] in 24 hour Urine

3.03

2.35

1.3

1.5

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

394

1.50

2.35

1.3

1.6

20.83

27.18

u/ml

—

(3003327) Ova and parasites identified in Stool by Light microscopy

156

1227

1.28

2.32

1.5

1.7

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

307

1.57

2.32

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

332

1.54

2.29

1.1

1.2

88.02

99.18

pmol/l

1.00

332

(3018333) Ribosomal P Ab [Presence] in Serum

286

1.58

2.24

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

297

1.55

2.16

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

115

1.92

2.15

1.4

1.17

mmol/l

0.02

115

(3008757) Leukocyte morphology finding [Identifier] in Blood

527

1.41

2.15

3.7

4.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

181

0.39

2.14

1.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

163

1304

1.26

2.14

2.3

133.40

119.40

ug/min

0.18

792

(3036525) Urea [Moles/time] in 24 hour Urine

2.78

2.13

2.8

3.5

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.78

2.13

1.0

140.80

102.22

titre

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

763

6946

1.12

2.08

1.3

48.44

35.91

iu/ml

0.87

216

2058

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

292

1.55

2.08

1.1

1.2

—

(3034891) Synovial lining cells/cells in Synovial fluid

230

1.61

2.04

1.1

1.6

3.55

4.08

0.09

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4078

41510

0.90

2.04

6.9

6.2

2.35

2.56

mmol/l

45.67

3873

38425

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

2.18

2.04

1.6

1.8

1.23

0.92

mmol/l

—

(3008037) Lactate [Moles/volume] in Venous blood

163

1313

1.25

2.03

4.1

3.4

1.60

1.66

mmol/l

0.44

157

1274

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

319

1.51

2.00

1.1

—

(3025159) Blasts/Leukocytes in Blood

475

4215

1.14

1.98

4.8

4.6

0.07

0.14

0.71

155

1218

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

988

9140

1.10

1.98

2.9

3.3

2.46

2.45

mmol/l

1.57

867

8186

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

304

1.52

1.97

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

304

1.52

1.97

1.2

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

171

1.70

1.96

4.0

2.4

9.23

9.96

kpa

1.03

171

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

171

1.70

1.96

4.0

2.4

4.96

4.78

kpa

0.23

171

(3000570) Elastase.pancreatic [Mass/mass] in Stool

173

1410

1.24

1.95

1.5

258.72

261.19

ug/g

0.05

113

873

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

219

2610

0.83

1.94

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

150

1.74

1.90

1.9

2.0

1.80

1.58

ratio

0.30

141

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.31

1.87

1.0

1.3

—

mmol/l

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

454

5096

0.88

1.86

1.4

—

(40768804) Tissue Pathology biopsy report

1599

16857

0.92

1.86

2.1

2.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

165

1349

1.23

1.83

1.5

2.48

12.41

iu/ml

0.83

266

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

311

1.48

1.80

2.8

2.6

212.72

238.32

e6/l

0.29

271

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

116

1.81

1.78

1.8

1.5

10.52

9.36

ug/l

0.40

116

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

304

1.48

1.77

2.6

2.5

349.15

522.97

e6/l

2.09

249

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

224

1.57

1.75

1.4

1.6

1.83

3.25

u/field

0.74

164

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.90

1.75

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4011

40790

0.91

1.73

6.1

5.5

4.09

4.41

mmol/l

75.85

3821

37932

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

257

1.52

1.73

1.6

1.5

—

(3046861) Legionella sp Ag [Presence] in Urine

2.67

1.72

1.1

1.0

—

(3032773) Endomysium IgG Ab [Titer] in Serum

347

0.57

1.72

1.3

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.13

1.71

1.5

2.0

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1954

18699

1.07

1.70

2.7

2.4

75.13

77.27

nmol/l

2.39

1772

16710

(3025130) Human papilloma virus identified in Specimen

210

1.58

1.70

1.7

2.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

118

1.78

1.70

1.3

1.5

0.28

0.32

mmol/l

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

4330

42696

1.11

1.68

47.2

22.7

139.36

139.65

mmol/l

11.44

4283

41938

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3985

40521

0.92

1.66

6.0

5.4

1.25

1.37

mmol/l

84.97

3778

37405

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

105

1.81

1.62

1.4

1.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1134

12058

0.92

1.61

3.7

3.5

0.01

0.11

estimate

0.78

428

3812

(3042111) Morphology [Interpretation] in Bone marrow Narrative

121

974

1.25

1.58

1.5

1.6

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

173

0.46

1.57

1.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

125

1011

1.24

1.57

1.7

1.6

1.23

0.88

nmol/l

2.72

111

842

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

321

1.44

1.57

1.2

1.5

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

272

1.47

1.56

2.2

2.1

87.45

196.47

ug/min

0.62

(3014133) Dog dander IgE Ab [Units/volume] in Serum

410

0.63

1.55

1.2

1.1

4.07

2.23

u/ml

0.27

213

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

348

0.60

1.54

1.1

1.0

0.90

0.35

u/ml

0.60

135

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

3.34

1.52

1.0

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.34

1.52

1.0

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

4337

43895

0.91

1.50

46.8

24.8

101.19

85.33

umol/l

66.51

4288

43396

(3023430) Cat dander IgE Ab [Units/volume] in Serum

382

0.63

1.50

1.1

12.95

3.85

u/ml

0.50

177

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

108

1.76

1.50

2.1

2.3

7.73

7.81

mmol/l

0.04

(3008401) Mugwort IgE Ab [Units/volume] in Serum

502

0.68

1.50

1.1

1.61

1.20

u/ml

0.17

227

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

232

2004

1.17

1.47

1.2

100.71

117.23

u/ml

0.27

676

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

351

1.40

1.47

1.1

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

605

0.71

1.47

1.3

1.1

0.73

2.07

u/ml

2.84

341

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

318

1.42

1.45

1.2

1.5

—

(3020393) Adenovirus Ag [Presence] in Stool

2.37

1.45

2.0

1.1

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

128

1050

1.22

1.44

1.2

—

19.68

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

507

1.33

1.44

1.4

1.3

0.20

0.23

nmol/l

0.27

421

(3005011) Chlamydia sp Ab [Titer] in Serum

2.25

1.40

1.3

1.6

—

(21494814) CD8 cells/Lymphocytes in Specimen

181

1.55

1.39

1.6

2.1

30.89

33.64

0.42

181

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.42

1.39

2.0

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

243

2779

0.87

1.38

2.3

2.5

8.02

19.81

au/ml

5.18

246

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

416

1.35

1.37

1.3

1.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

4330

42775

1.09

1.35

47.6

22.9

4.10

4.01

mmol/l

95.03

4281

41965

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

391

1.36

1.35

1.0

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1652

17230

0.94

1.34

4.3

3.9

0.01

0.06

estimate

1.13

463

4087

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

588

5412

1.10

1.34

16.0

7.6

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

466

0.68

1.34

1.2

1.1

1.86

1.33

u/ml

0.25

247

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

1.33

0.0

1.6

—

(3005322) IgE [Units/volume] in Serum or Plasma

279

2466

1.14

1.31

1.3

240.78

281.93

u/ml

0.42

268

2277

(3016228) CD19 cells/cells in Blood

184

1.52

1.31

1.8

2.1

11.00

7.86

0.35

174

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3963

40208

0.93

1.29

6.1

5.6

6.45

6.11

mmol/l

30.91

3684

36691

(3040893) Potassium [Moles/volume] in Capillary blood

2.78

1.28

6.0

2.7

4.28

4.58

mmol/l

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.78

1.28

1.0

1.2

268.80

252.44

nmol/l

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

100

1224

0.81

1.26

1.9

1.7

—

30.85

—

(40768446) Kidney Pathology biopsy report

194

1.50

1.26

1.9

1.7

—

(3000012) Reticulocyte production index

108

885

1.23

1.26

2.1

2.2

0.87

0.89

0.15

609

(3019225) pH of Specimen

489

4479

1.10

1.25

6.1

4.7

7.36

7.35

0.48

402

3275

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

159

0.50

1.24

1.4

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

195

1.49

1.24

1.5

1.7

11.55

8.77

nmol/l

0.13

166

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

262

1.42

1.22

1.7

1.6

6.50

7.75

u/l

0.17

212

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.63

1.21

1.4

1.8

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

417

1.32

1.21

1.7

2.3

1014.72

5341.96

u/l

1.68

154

(3019150) Specific gravity of Urine by Refractometry

964

10201

0.93

1.20

4.8

4.1

1.02

1.16

kg/l

0.50

685

6945

(3045142) Bone marrow Pathology biopsy report

638

1.26

1.20

1.2

1.3

—

(4024509) Urine culture

173

2004

0.86

1.20

2.2

2.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

1203

0.82

1.18

4.6

4.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.11

1.18

2.8

1.5

—

(3029937) Albumin [Presence] in Urine by Test strip

1363

13027

1.06

1.18

4.5

4.1

0.00

estimate

0.09

477

4373

(40768797) Stomach Pathology biopsy report

668

6225

1.08

1.17

1.3

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

393

0.69

1.16

5.1

3.8

25.44

36.51

u/ml

0.76

383

(4133840) Spirometry

126

0.48

1.16

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2318

22506

1.06

1.16

2.6

—

(3051339) Copper [Moles/volume] in Blood

2.50

1.15

1.0

1.3

18.02

15.67

umol/l

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

979

0.80

1.14

1.5

382.07

894.33

e6/l

0.96

777

(3027923) C peptide [Moles/volume] in Serum or Plasma

283

1.38

1.14

1.3

1.79

1.18

nmol/l

1.07

199

(3020491) Glucose [Moles/volume] in Blood

318

1.36

1.12

2.0

8.53

6.94

mmol/l

1.20

220

(3015171) Extractable nuclear Ab [Units/volume] in Serum

169

1462

1.16

1.11

1.2

0.13

0.71

u/ml

—

112

(3013139) Helicobacter pylori Ag [Presence] in Stool

235

2645

0.88

1.10

1.2

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

515

0.74

1.10

1.1

8.04

3.93

u/ml

0.64

262

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

329

1.34

1.08

1.3

1.2

—

(21494434) Karyotype in Bone marrow

514

1.27

1.07

1.1

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

227

1.41

1.07

1.3

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

227

1.41

1.07

1.3

1.5

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

385

0.70

1.06

1.0

276.81

309.45

ng/l

0.33

272

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

968

0.81

1.05

1.4

96.27

26.35

e6/l

0.40

720

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

262

1.38

1.05

2.5

216.08

203.07

u/l

0.63

256

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.27

1.03

1.8

1.7

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

2.27

1.03

1.2

1.5

37.52

32.75

nmol/l

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

204

1.42

1.02

1.0

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

609

1.24

1.00

1.4

1.3

0.20

0.26

nmol/l

0.37

(3021601) Nitrite [Presence] in Urine by Test strip

2352

22912

1.05

0.99

4.1

3.9

0.00

estimate

1.08

547

4911

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

379

0.71

0.99

1.0

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

133

0.53

0.98

1.3

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

135

0.52

0.98

1.3

1.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

198

1.42

0.97

1.9

2.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

198

1.42

0.97

1.9

2.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

881

0.81

0.97

1.2

1.1

10.98

7.06

eliau/ml

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2847

27882

1.05

0.95

4.0

3.5

77.52

56.30

u/l

13.86

2690

26045

(3011897) Casein IgE Ab [Units/volume] in Serum

1.89

0.94

1.3

0.63

1.52

u/ml

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

386

0.72

0.93

1.0

775.62

713.42

ng/l

0.25

266

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

386

0.72

0.93

1.0

34.06

41.83

ng/l

0.60

268

(40757373) Influenza virus identified in Isolate

101

1.59

0.93

1.1

1.6

—

(3023511) Choriogonadotropin [Units/volume] in Urine

150

1.47

0.92

1.4

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

509

1.24

0.90

1.4

1.3

—

nmol/l

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

1.60

0.90

1.3

1.2

1.83

184.13

mg/l

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

280

1.32

0.88

1.0

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

127

0.55

0.88

2.7

2.9

4024.57

64.13

ug/l

—

127

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

229

2539

0.90

0.88

1.2

1.3

48.38

57.77

au/ml

—

179

(40761539) Cells [Type] in Urine sediment by Light microscopy

119

1.51

0.88

1.0

1.2

—

(3019174) dRVVT (LA screen)

2.00

0.87

1.2

1.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

212

1.37

0.86

1.9

1.8

39.78

39.90

g/l

0.04

212

(3000093) Morphology [Interpretation] in Blood Narrative

549

1.22

0.86

1.1

—

(3017704) Immunofixation for Urine

318

1.29

0.83

1.4

1.6

—

(40768795) Lymph node Pathology biopsy report

443

1.24

0.83

1.3

1.2

—

(44806071) Cardiolipin IgM antibody measurement

1.74

0.82

1.0

1.1

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

146

1.44

0.82

2.9

1.9

80.32

55.99

ug/l

0.58

140

(3008898) HLA-B27 [Presence]

1077

0.85

0.81

1.0

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

1.70

0.80

1.1

1.0

—

(3035350) Ketones [Presence] in Urine by Test strip

2370

23177

1.04

0.79

4.2

3.9

7.51

3.87

estimate

0.38

552

4999

(40768441) Liver Pathology biopsy report

330

1.28

0.78

1.3

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

712

1.18

0.78

1.1

187.56

278.41

iu/ml

—

149

(3052592) Norovirus Ag [Presence] in Stool

1.56

0.78

1.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

208

1.35

0.77

1.5

2.1

5.68

12.24

umol/l

1.31

137

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

243

1.32

0.77

2.2

3.6

1.95

1.22

0.55

243

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.76

0.0

1.9

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.76

0.0

1.0

—

8.19

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.70

0.75

1.6

1.4

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.70

0.75

1.6

1.4

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.70

0.75

1.6

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

596

1.19

0.74

3.5

2.5

1.17

1.19

mmol/l

1.99

586

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

116

1.47

0.74

1.1

1.0

—

(3044927) Protein electrophoresis panel - Urine

542

1.20

0.73

1.2

1.1

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

3321

33673

0.96

0.73

45.2

24.0

329.58

333.01

g/l

79.52

3293

33481

(3000285) Sodium [Moles/volume] in Blood

107

0.56

0.72

1.8

1.2

136.17

139.35

mmol/l

—

(3027944) Amphetamines [Presence] in Urine

935

0.85

0.71

2.7

2.0

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

273

1.28

0.71

1.6

1.4

11.56

6.84

u/l

0.36

236

(3047189) Immunofixation for 24 hour Urine

282

1.28

0.70

1.4

1.7

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

679

6466

1.06

0.70

1.2

1.3

10.04

12.37

u/ml

0.44

261

2369

(3024522) Salmonella sp identified in Specimen by Organism specific culture

564

1.19

0.69

1.3

1.5

—

(3020650) Glucose [Presence] in Urine

143

0.63

0.69

1.3

1.7

0.00

0.04

estimate

—

143

(3041354) Potassium [Moles/volume] in Venous blood

611

1.18

0.68

3.4

2.4

4.20

4.11

mmol/l

0.89

601

(3035285) Chloride [Moles/volume] in Venous blood

611

1.18

0.68

3.4

2.4

105.57

105.71

mmol/l

0.07

601

(3000764) Benzodiazepines [Presence] in Urine

941

0.86

0.68

2.7

2.0

—

(44806420) Estimation of glomerular filtration rate

386

0.78

0.68

2.5

2.6

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

127

1.42

0.67

1.3

0.28

0.30

g/l

0.43

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

573

0.82

0.67

1.5

1.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

498

5268

0.94

0.67

3.3

4.5

9.80

25.09

ug/l

3.20

411

4430

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

249

1.29

0.67

1.1

1.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1003

0.87

0.66

1.3

3.87

mmol/l

0.00

945

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

648

0.83

0.66

1.4

1.5

—

(3028300) Cannabinoids [Presence] in Urine

949

0.86

0.66

2.7

2.0

—

(3014271) Vancomycin [Susceptibility]

250

1.28

0.65

2.9

—

(3027008) Opiates [Presence] in Urine

947

0.86

0.64

2.7

2.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

189

1.32

0.64

1.1

1.3

174.04

185.29

mmol/24h

0.27

189

(3009261) Glucose [Presence] in Urine by Test strip

2377

23323

1.04

0.63

4.2

4.0

0.05

0.08

estimate

0.19

484

4604

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

130

0.61

0.63

1.0

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

129

1.40

0.63

1.0

1.1

7.46

4.19

u/ml

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

121

1.41

0.62

1.2

33.83

30.75

0.11

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

117

1040

1.13

0.62

1.2

1.3

—

(3017509) Phencyclidine [Presence] in Urine

1.67

0.61

1.8

1.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

187

0.69

0.60

1.6

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

200

1.30

0.60

1.9

2.4

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.60

0.0

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

139

0.65

0.60

1.6

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.57

0.60

1.3

1.5

48.25

46.82

umol/l

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.60

0.0

1.4

—

0.17

—

(3028707) Methadone [Presence] in Urine by Screen method

418

1.20

0.58

3.1

2.7

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.51

0.58

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

113

0.62

0.58

1.0

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

208

0.72

0.58

1.1

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.72

0.57

2.7

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

264

0.76

0.57

1.0

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

1.54

0.55

1.0

1.6

2.58

1.65

ug/l

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

284

1.23

0.55

3.3

2.0

162.53

128.80

ng/l

0.51

284

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

570

1.16

0.54

1.3

1.5

—

(40768793) Breast Pathology biopsy report

547

0.84

0.54

1.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

579

0.84

0.54

1.2

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

306

0.78

0.54

4.3

5.8

29.25

42.09

u/ml

0.55

(3038515) Glucose [Moles/volume] in Venous blood

123

1109

1.11

0.53

4.7

3.6

7.44

7.63

mmol/l

0.40

117

1078

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

249

1.25

0.53

1.9

2.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

578

0.85

0.53

1.2

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.43

0.52

1.4

1.6

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

117

1.37

0.52

1.6

1.7

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

192

0.73

0.52

1.9

1.5

24.71

27.59

umol/l

1.35

180

(3025468) Yersinia sp identified in Specimen by Organism specific culture

545

1.16

0.52

1.3

1.5

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

100

1.40

0.51

1.2

1.5

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.50

0.51

1.0

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

203

0.74

0.51

1.1

0.97

1.19

u/l

—

100

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

546

1.16

0.51

1.3

1.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

168

0.71

0.50

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

297

1.21

0.50

2.3

2.8

42.61

36.95

0.98

173

(3005988) Vibrio sp identified in Specimen by Organism specific culture

548

1.15

0.49

1.3

1.5

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.49

0.47

1.6

2.4

0.14

0.36

u/field

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.46

0.46

1.4

1.6

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

164

1.28

0.46

1.4

1.3

—

(3006270) Folate [Moles/volume] in Blood

364

0.82

0.46

1.2

355.84

342.89

nmol/l

0.11

290

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

561

1.14

0.46

1.4

1.5

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.43

0.46

1.4

1.9

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.38

0.46

1.2

1.4

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

243

0.78

0.45

8.8

6.5

51.00

680.45

u/ml

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

310

1.19

0.45

1.8

1.6

97.78

92.32

umol/l

0.44

310

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

121

0.66

0.45

1.0

1.1

—

(3002256) Pathology report gross observation

587

6097

0.96

0.44

1.3

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

152

0.72

0.44

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

523

0.86

0.43

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.37

0.43

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

184

1.25

0.43

1.0

1.1

1735.83

1588.99

miu/ml

0.23

184

(3016879) Cocaine [Presence] in Urine

882

0.89

0.43

2.7

2.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.61

0.43

1.2

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

153

1415

1.08

0.43

1.6

18.45

20.83

u/ml

0.27

285

(40758292) HTLV I+II Ab panel - Serum

0.64

0.42

1.2

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

462

1.15

0.42

1.1

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

350

1.17

0.42

2.8

3.0

45.16

32.63

mg/l

0.82

269

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

861

8364

1.04

0.41

1.3

2.03

2.00

u/ml

0.02

218

2189

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

1.52

0.41

17.8

13.6

321.00

237.35

e6/l

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.41

0.0

1.0

—

(3013762) Body weight Measured

0.00

0.41

0.0

1.3

—

(37019676) Renin [Units/volume] in Plasma --supine

0.00

0.41

0.0

1.3

—

27.31

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.41

0.0

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

380

0.84

0.40

1.1

—

83.92

—

(4211845) Urine protein measurement

205

0.78

0.40

2.6

3.4

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.43

0.39

4.0

3.5

—

(3006969) Lambda light chains [Mass/volume] in Urine

0.00

0.39

0.0

1.1

—

0.14

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.1

—

0.10

—

(3000330) Specific gravity of Urine by Test strip

227

2406

0.94

0.39

3.6

3.5

1.02

ratio

0.04

209

2197

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.34

0.38

1.1

1.0

—

(3015736) pH of Urine

1876

18468

1.03

0.37

3.8

3.5

6.19

6.21

0.26

931

10285

(3004809) Band form neutrophils/Leukocytes in Blood

102

934

1.09

0.37

3.4

3.8

1.60

1.65

0.05

829

(3032057) Clostridioides difficile [Presence] in Stool

107

1.31

0.37

1.7

2.0

—

(3003694) ABO and Rh group [Type] in Blood

1183

12085

0.97

0.37

1.4

1.3

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

125

1.28

0.37

1.8

1.5

59.13

560.07

nmol/24h

1.34

125

(3019420) Tryptase [Mass/volume] in Serum or Plasma

216

1.20

0.36

1.5

1.6

10.09

9.73

ug/l

0.04

195

(3030981) Hyaline casts [#/volume] in Urine by Automated count

453

4363

1.04

0.36

2.5

2.6

0.72

0.46

e6/l

1.48

442

4214

(3051387) C reactive protein [Mass/volume] in Capillary blood

963

0.91

0.35

5.6

3.6

27.43

30.12

mg/l

0.34

665

(4198724) Urine methamphetamine measurement

135

1.26

0.35

1.8

1.7

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

125

0.72

0.35

1.0

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

320

1.16

0.34

1.6

1.7

342.00

321.23

mu/l

0.14

244

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

181

1.22

0.34

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

679

0.90

0.34

4.5

5.3

333.05

348.55

umol/l

0.39

587

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

209

1.20

0.34

1.1

1.3

4.44

279.33

ug/l

—

102

(3017732) Neutrophils [#/volume] in Blood

583

5652

1.04

0.33

3.1

3.5

5.22

4.85

e9/l

0.26

502

4829

(3038177) Helicobacter pylori Ab [Presence] in Serum

567

1.11

0.33

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.67

0.32

1.5

2.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

220

0.82

0.32

1.1

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

209

0.81

0.32

1.2

0.66

0.54

ratio

0.30

120

(3017354) Segmented neutrophils/Leukocytes in Blood

607

1.11

0.32

3.0

3.8

63.93

57.87

1.47

519

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

1.33

0.32

1.1

1.0

3.77

5.98

u/ml

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

128

1.25

0.31

1.4

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

999

9779

1.03

0.31

1.7

1.8

22473684.40

30102648.80

pmol/l

0.19

841

8119

(3023323) Follitropin [Units/volume] in Serum or Plasma

860

0.92

0.30

1.5

1.4

31.47

26.10

iu/l

0.56

717

(3049717) Cytology report of Urine Cyto stain

250

2390

1.05

0.29

2.8

2.9

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

112

1.25

0.28

1.1

1.3

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1.29

0.28

1.0

2.0

1.52

4.50

ug/l

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

120

0.75

0.27

1.0

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.23

0.27

1.0

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

490

1.10

0.26

1.5

1.4

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.30

0.26

1.0

1.3

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

549

1.09

0.25

1.1

14.61

19.15

au/ml

—

117

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

148

0.81

0.24

1.1

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

4012

39948

1.02

0.24

34.6

18.5

69.74

77.34

ml/min/173m2

76.29

3863

37327

(3028679) Herpes simplex virus Ab [Presence] in Serum

189

1.16

0.24

1.2

1.1

—

(3013727) Leukocytes other/Leukocytes in Blood

161

1.18

0.24

2.8

3.8

59.08

55.22

0.36

156

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

186

1944

0.96

0.23

2.8

3.7

358.61

3004.40

u/ml

1.15

157

1701

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.32

0.23

1.0

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.25

0.22

1.8

1.5

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.19

0.21

1.0

1.2

4.20

11.74

u/l

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.21

0.0

1.0

—

1115.91

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.5

—

324.50

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

216

2081

1.04

0.21

1.7

1.8

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

25.17

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

211

1.14

0.20

1.1

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

219

0.87

0.20

1.0

1.1

12.86

11.35

iu/ml

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

115

0.78

0.20

1.2

1.3

2.90

3.69

umol/l

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

115

0.78

0.20

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method Nominal

624

0.93

0.19

8.7

2.8

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

161

1678

0.96

0.19

1.0

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

218

0.87

0.19

5.1

7.0

28.02

293.07

ug/l

1.07

145

(3008295) Osmolality of Serum or Plasma

539

1.08

0.19

1.4

1.3

276.52

278.67

mosm/kgh2o

0.21

406

(3006462) Nitrate [Presence] in Urine

186

0.86

0.19

2.6

3.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1.22

0.19

1.3

1.5

47.51

50.39

ug/l

0.11

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.15

0.19

1.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.15

0.19

1.0

1.3

—

(4146454) Self-monitoring of blood glucose

580

1.07

0.18

2.6

2.7

—

(3036670) Protein [Mass/volume] in Synovial fluid

166

1.15

0.18

1.1

1.2

37.84

39.80

g/l

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.17

0.17

1.9

2.2

16.27

17.91

umol/l

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

115

1098

1.05

0.17

1.2

3.22

3.59

u/ml

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

115

1100

1.05

0.17

1.2

2.82

6.91

u/ml

1.69

154

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.18

0.16

1.0

1.1

—

(3045414) Leukocytes [Presence] in Urine

449

4403

1.02

0.16

2.2

2.1

0.00

0.01

estimate

1.30

876

(3025577) Chromium [Mass/volume] in Blood

328

0.91

0.15

2.1

2.2

1.74

2.12

ug/l

0.42

274

(3051101) Glucose [Moles/volume] in Cord blood

1.13

0.15

7.9

6.8

9.71

8.28

mmol/l

—

(3022145) Colonoscopy Study observation

531

5223

1.02

0.14

1.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.80

0.14

1.4

2.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

246

1.10

0.14

1.1

1.3

—

(40765096) Chromosome analysis panel by Banding

179

1.12

0.14

1.1

—

(3023410) Appearance of Cerebral spinal fluid

429

0.93

0.14

1.5

1.6

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

286

1.08

0.13

1.5

1.3

20.94

23.51

u/l

0.20

235

(3020961) Endomysium IgA Ab [Titer] in Serum

160

1649

0.97

0.13

1.2

1.1

28.33

166.15

titre

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

112

1162

0.96

0.13

2.4

3.7

851.08

781.30

u/ml

0.05

1080

(3036071) Salmonella sp Ab [Titer] in Serum

113

1.15

0.13

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

248

1.09

0.12

1.1

1.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3903

38932

1.01

0.12

5.4

4.6

1.46

1.32

mmol/l

20.71

3681

35564

(3014051) Protein [Presence] in Urine by Test strip

1185

11947

0.99

0.11

3.1

3.0

0.00

0.05

2.67

322

(3022621) pH of Urine by Test strip

344

3387

1.02

0.10

2.7

5.92

6.02

1.38

268

2383

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

453

0.95

0.10

1.4

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.11

0.09

3.8

2.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.11

0.09

1.2

1.3

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

145

0.90

0.09

1.5

1.2

13.77

10.86

mm/h

0.33

145

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

706

0.96

0.09

2.0

2.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

227

0.92

0.09

1.2

1.6

—

(3001186) Copper [Moles/volume] in Serum or Plasma

113

0.88

0.08

1.3

1.1

14.85

15.73

umol/l

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

113

0.88

0.08

1.1

1.3

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.83

0.08

1.0

26.14

48.13

iu/ml

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

568

1.04

0.08

3.5

3.6

11.83

16.62

nmol/l

0.19

559

(3000034) Microalbumin [Mass/volume] in Urine

440

1.05

0.08

3.5

3.2

12.38

62.32

mg/l

2.16

346

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.06

0.08

1.1

1.6

—

1.08

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

598

1.04

0.08

1.7

2.1

19.47

24.29

mg/l

0.42

204

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

429

0.96

0.07

1.1

2.59

2.49

eliau/ml

0.04

175

(36660697) Celiac disease serology panel - Serum

292

2960

0.99

0.07

1.1

1.2

—

(3045424) Erythrocytes [Presence] in Urine

225

2285

0.98

0.07

2.3

2.2

0.85

0.41

estimate

0.19

643

(3009214) Lutropin [Units/volume] in Serum or Plasma

108

1106

0.98

0.07

1.5

1.4

9.73

7.67

u/l

0.84

882

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

422

1.04

0.07

1.3

—

(3036048) Francisella tularensis Ab [Titer] in Serum

101

0.89

0.06

1.2

1.1

—

624.00

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

142

0.92

0.06

1.0

1.4

—

(4015189) Microbial culture of sputum

142

0.92

0.06

1.8

2.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3979

39840

0.99

0.06

8.2

7.1

42.51

40.19

mmol/mol

29.32

3784

37125

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.11

0.05

1.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

120

0.92

0.05

1.1

1.9

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

474

0.97

0.04

1.5

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

288

1.04

0.04

1.3

1.4

1.88

2.25

u/ml

0.09

172

(3048689) Calprotectin [Mass/mass] in Stool

469

4664

1.01

0.03

2.2

2.5

141.32

158.53

ug/g

0.51

371

3787

(40768443) Skin Pathology biopsy report

209

2072

1.01

0.03

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

612

0.98

0.03

1.1

1.4

323.00

291.54

pmol/l

0.27

508

(1001926) Buprenorphine [Presence] in Urine by Screen method

731

0.98

0.02

2.6

2.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

224

2255

0.99

0.02

1.9

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

152

1.05

0.02

1.1

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

127

0.94

0.01

1.2

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

243

1.03

0.01

1.0

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

838

0.99

0.01

2.1

2.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.06

0.01

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

106

0.94

0.01

1.0

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

144

1.04

0.00

1.9

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

154

1.04

0.00

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

154

1.04

0.00

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

154

1.04

0.00

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

154

1.04

0.00

1.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

135

0.96

0.00

1.5

1.6

—

(3016750) Collection duration of Urine

308

1.01

0.00

2.3

2.1

503.95

490.69

min

0.31

225

(4034850) Laboratory test

132

1318

1.00

0.00

26.0

11.3

—

(3011985) Renin [Units/volume] in Plasma

664

0.99

0.00

1.3

1.4

142.64

69.52

mu/l

0.45

595

(44813793) Dust mix specific IgE antibody measurement

221

1.00

0.00

1.0

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

240

2403

1.00

0.00

2.5

2.4

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.0

—

263.57

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.01

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

47.57

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.1

—

1.47

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.0

2.3

—

21.39

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

0.87

0.00

1.2

1.1

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.0

1.3

—

1.86

—

(4212803) Bone marrow aspirate examination

0.98

-0.00

1.2

1.1

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

-0.00

0.0

1.2

—

0.36

—

(3039528) Macrophages/Leukocytes in Pleural fluid by Manual count

0.00

-0.00

0.0

3.8

—

32.50

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.6

—

2.55

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3004775) Volume in Urine collected for unspecified duration

440

1.00

-0.00

2.4

2.3

720.07

639.28

0.50

285

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.86

-0.00

1.0

1.1

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.02

-0.00

1.0

1.1

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

1.26

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.97

-0.00

1.5

1.3

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

6.0

—

0.25

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

0.91

-0.00

5.3

5.5

52.33

48.04

ug/min

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.6

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

8.44

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

1868.33

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

370

1.00

-0.00

1.6

1.9

1.33

1.44

u/field

0.05

204

(40765089) Chromosome analysis panel - Blood by G-banded

0.86

-0.00

1.0

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

0.91

-0.00

3.3

1.8

46.73

39.21

pmol/l

—

(3007463) Buprenorphine [Presence] in Urine

0.00

-0.00

0.0

4.6

—

(3028717) Thiamine [Mass/volume] in Blood

0.91

-0.00

1.0

1.2

56.83

64.77

ug/l

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: I9_DILATED_CARDIOMYOPATHY – Dilated cardiomyopathy

GWS hits: 24

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Dilated cardiomyopathy

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Dilated cardiomyopathy (I9_DILATED_CARDIOMYOPATHY)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints